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Bovine tuberculosis (bTB), caused by Mycobacterium bovis, is a chronic infectious disease 
known to occur in free-ranging mammals, captive wildlife, and livestock.  M. bovis forms part 
of the Mycobacterium tuberculosis complex (MTC), a genetically related group of bacteria that 
cause tuberculosis in humans or other species. bTB eradication efforts are complicated by the 
occurrence of wildlife reservoirs of the disease such as the African buffalo (Syncerus caffer). 
Buffalo in the Kruger National Park and Hluhluwe-iMfolozi Game Reserve are affected by 
endemic bTB and there is the potential for M. bovis to spill-over into other domestic or wild 
animals, including zoonotic transmission to humans. Current standard diagnostic tests lack the 
required sensitivity to successfully detect all infected animals and are known to be ineffective 
in animals who have become anergic in the late stages of disease.  Antibodies have been shown 
to correlate with disease pathology due to a high antigen burden and are able to be detected in 
anergic animals. The aim of this study was to characterize the humoral (antibody mediated) 
immune response in bTB-positive buffalo using different molecular techniques. Towards this 
aim, an in-house PPD ELISA was developed to detect antibodies against M. bovis and was 
compared to the Chembio® DPP VetTB, a commercial antibody assay. Both tests were able to 
detect M. bovis-specific antibodies in bTB-positive buffalo and there was good correlation 
between the two. We aimed to further assess the humoral response by investigating the 
diagnostic performance of monocyte chemotactic protein 1 (MCP-1), a cytokine involved in 
the activation of B-cell proliferation and class switching. There was a significant difference in 
antigen-specific MCP-1 release between bTB-positive and bTB-negative buffalos, suggesting 
there is promise for the use of MCP-1 as a biomarker, although sensitivity was low. 
Furthermore we evaluated the plasma stability of the MCP-1 protein during storage on protein 
saver cards (PSC) as well as after heat-treatment at 65°C. After 11 days at room temperature 
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on the PSC, MCP-1 was still detected at similar levels. MCP-1 concentrations were higher after 
heat-treatment and correlated with the dilution factor. Lastly, we aimed to determine the 
stability of 8 reference genes to be used in a whole-blood qPCR gene expression assay in 
buffaloes. Selected gene transcripts of the African buffalo were sequenced using primers from 
the domestic cow and it was shown that PPIA is the most stable reference genes whereas 
GAPDH is the most unsuitable for use under our experimental conditions. In conclusion, the 
use of serological tests for the detection of M. bovis infected buffalo are disadvantaged by their 
low sensitivity, although using them in combination with conventional tests may provide useful 
information on the immune status of the animal. MCP-1 shows promise as a biomarker of 
disease in buffalo and its stability means that transporting of plasma samples can be made safe 
and efficient by heat-treating samples and storing them on PSC. Further research is needed to 
fully optimize a diagnostic GEA for bTB in buffaloes, however, we have shown that PPIA is a 

















Beestuberkulose (bTB) word veroorsaak deur die bakterie Mycobacterium bovis en is ‘n 
kroniese siekte in beeste en wild. M. bovis is deel van die M. tuberculosis kompleks, ‘n groep 
geneties verwante bakterie wat tuberkulose veroorsaak in die mens en verskeie ander spesies. 
Die bekeuring van bTB word bemoeilik deur die voorkoms van die siekte in wild spesies soos 
die Kaapse buffel (Syncerus caffer). Buffels in die Kruger Nasionale Park en Hluhluwe-
iMfolozi Park is endemies geïnfekteer en die moontlikheid van oordrag na vee en ander wild 
spesies, asook na die mens, bestaan. Onlangse navorsing het bevind dat die huidige beskikbare 
diagnostiese toetse nie die nodige sensitiwiteit beskik om alle geïnfekteerde diere te identifiseer 
nie, asook oneffektief is in diere met n gevorderde siekte toestand. 
Vorige navorsing het bevind dat die mate van teenliggaam teenwoordigheid in geinfekteerde 
diere sterk korreleer met sy siektestoestand as gevolg van die groot hoeveelhede antigeen 
teenwoordig in letsels. Die doel van die studie was om die humorale immuun reaksie in bTB-
positiewe buffels te karakteriseer deur gebruik te maak van verskeie molekulêre tegnieke. In 
lig van hierdie doelwit is ‘n PPD ELISA ontwikkel om die teenwoordigheid van 
teemliggaampies teen M. bovis te meet en die resultate te vergelyk met die van ‘n kommersiële 
beskikbare toets, die Chembio DPP toets. Albei toetse kon die M. bovis-spesifieke 
teenliggaampies in die bTB-positiewe groep optel en albei toetse se resultate het goed 
gekorreleer.  
Die humorale reaksie was verder gekarakteriseer deur die vrystelling van MCP-1 in M. bovis 
antigeen gestimuleerde bloed te meet. Hierdie sitokien is verantwoordelik vir B-sel proliferasie 
asook klas omskakeling gedurende gevorde infeksies. Daar was ‘n betekenisvolle verskil 
gevind in antigeen-spesifieke MCP-1 vrystelling tussen bTB-positiewe en bTB-negatiewe 
buffels. Hierdie resultate ondersteun die potensiele gebruik van MCP-1 as ‘n biologiese merker 
van infeksie, al was die sensitiwiteit laag. Verder was die stabiliteit van die MCP-1 sitokien 
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geevalueer deur die meting daarvan na storing van bloed plasma op Whatman filtreer papier, 
asook na die hitte-behandeling daarvan by 65 ºC. Na 11 dae op filtreer papier was die 
konsentrasie van MCP-1 dieselfde as in plasma gestoor by -80 ºC. MCP-1 plasma konsentrasies 
was hoër na hitte behandeling as by -80 ºC storing en het goed gekorreleer met die verdunnings 
faktor.  
Laastens het ons die stabiliteit van 8 verskillende verwysings gene ge-evalueer om die mees 
stabiel gene te identifiseer vir die verdere gebruik daarvan in n kwantitatiewe ware tyd 
polimerase kettingreaksie toets vir die diagnose van bTB in buffels. Verder was die mees 
stabiele gene se boodskapper RNA nukleotied volgorde bepaal deur “primers” te ontwerp vanaf 
gepubliseerde beskikbare informasie beskikbaar oor elk een vir beeste. Die mees stabiel 
verwysings geen was PPIA, met GAPDH as die minder toepaslike kandidaat gedurende hierdie 
eksperimentele omstandighede. 
Ten slotte, serologiese toetse se gebruik vir die diagnose van M. bovis infeksie in buffels word 
benadeel deur hulle lae sensitiwiteit wel die gebruik van hierdie toetse in kombinasie met 
konvensionele toetse mag dalk nuttige informasie bied oor die immuun status van n dier. MCP-
1 toon potensiaal as n biologiese merker van infeksie in buffels en die stabiliteit onder verskeie 
kondisies ondersteun die moontlikheid om die vervoer van bloed monsters meer doeltreffend 
en veiliger te maak deur die geprosesseerde plasma by hoë temperature te skok en te stoor op 
filtreer papier. Alhoewel ons bewys het dat die PPIA die mees toepaslike verwysings geen is 
vir die gebruik in n diagnostiese geen uitdrukkings-toets vir bTB diagnose in Kaapse buffels, 
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µg Microgram 
µl Microliter 
µM Micro Molar 
3D Three dimensional  
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Ab Antibody 
ACTB Beta actin 
B2M Beta-2-Microglobulin 
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Cq Quantification cycle 
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ESAT-6 Early secretory antigenic target 
GAPDH Glyceraldehyde-3-phosphate dehydrogenase 
GEA Gene expression analysis 
H2O2 Hydrogen peroxide 
H3F3A H3 histone, family 3A 
HPRT1 Hypoxanthine phosphoribosyltransferase 1 
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M Molar 
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Chapter 1 - Introduction: 
Bovine tuberculosis (bTB), caused by Mycobacterium bovis, is a chronic infectious disease 
known to occur in free-ranging mammals, captive wildlife, and livestock (Fitzgerald et al. 
2013).  M. bovis forms part of the Mycobacterium tuberculosis complex (MTC), a genetically 
related group of bacteria that can cause tuberculosis in humans or other species (Michel 2008). 
bTB has become an issue of public health and economic importance due to increasing wildlife-
livestock-human interfaces, with worldwide annual losses to agriculture of $3 billion (Garnier 
et al. 2003). The outcome of infection with M. bovis may vary, depending on the host species 
and other factors, such as age, animal behaviour, route of infection and environmental 
conditions (Neill et al. 2001). Common routes of exposure in cattle include direct inhalation of 
aerosols containing M. bovis from infected animals, or indirectly from contaminated water 
and/or pastures (Hassan et al. 2014). Infections may remain subclinical for years and can be 
reactivated during stress, old age or in immunocompromised individuals (De Vos et al. 2001). 
As the disease progresses, animals develop lesions in the infected tissues. Lesions in bovids 
are manifested as granulomas or tubercles which are characterized by a caseous or mineralized 
necrotic core of tissue surrounded by a zone of inflammation. The size can vary from 
microscopic to macroscopic lesions measuring several centimetres, while their distribution, 
appearance and severity differs between as well as within host species (Michel 2008). 
Tuberculous lesions in African buffalo (Syncerus caffer) occur most frequently in lymphatic 
tissue of the thoracic cavity, namely the bronchial and mediastinal lymph nodes (Laisse et al. 
2011). The second most frequent site for lesions are lymph nodes of the head region such as 
the retropharyngeal and submaxillary nodes, and also tonsillar tissues from field cases of 
bovine tuberculosis (Neill et al. 2001, Laisse et al. 2011). Often tuberculous lesions in the lungs 
are recorded less frequently than that of the thoracic lymph nodes; however, these lower 
numbers may be due to the difficulty of detecting very small, singular lesions in the lungs due 
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to their large volume.  The almost exclusive distribution of lesions in the lung and upper 
respiratory tract suggests that the primary route of infection in African buffalo is aerosol 
inhalation (Neill et al. 2001, Laisse et al. 2011). African buffalo may remain infected for many 
years before death; however, those that reach an advanced stage of disease may show clinical 
signs including coughing, debilitation, emaciation, and lagging behind when chased (De Vos 
et al. 2001, Renwick et al. 2007). 
M. bovis is known to have one of the widest host ranges of all the MTC bacteria and can spill-
over into a variety of domestic and wild animals, including zoonotic transmission to humans 
(Musoke et al. 2015). Worldwide, more than 60 wild mammal species have been shown to be 
infected with M. bovis (de Lisle et al. 2002). The control of bTB is complicated by the 
occurrence of wildlife reservoirs of the disease such as the African buffalo, European badger 
(Meles meles), white-tailed deer (Odocoileus virginianus), and brush-tail possum (Trichosurus 
vulpecula) which pose a threat for reinfection of livestock (De Garine-Wichatitsky et al. 2013, 
Fitzgerald et al. 2013). African buffalo in the Kruger National Park and Hluhluwe-iMfolozi 
Game Reserve are affected by endemic bTB (Fitzgerald et al. 2013). Transmission to other 
wildlife species in these parks occurs through spill-over from buffalo through predation, 
scavenging or contaminated habitat, although direct transmission is also a possibility (Michel 
et al. 2006).  
In South Africa there is a need to develop novel diagnostic strategies to effectively manage and 
prevent the spread of M. bovis. One of the main approaches to controlling bTB in livestock 
herds is test and slaughter. This method of disease control has been effective in eradicating TB 
from certain locations, and relies on the slaughter of any animals testing positive on the TST. 
Test and slaughter has been widely used with great success in countries such as New Zealand, 
Australia and the USA (Tweddle and Livingstone 1994, Olmstead and Rhode 2004). However, 
the effectiveness of this strategy is limited where free-ranging wildlife reservoirs of the disease 
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are present.  Logistical, economic, and safety constraints of wildlife capture and handling, lack 
of available diagnostic tools, and lack of information about infected populations complicates 
surveillance and management efforts (Kaneene et al. 2010). Poorly established control 
programs in countries such as South Africa are due to a lack of economic and socio-political 
driving forces (Michel et al. 2006). In order to effectively monitor and manage bovine 
tuberculosis in wildlife, advances in ante-mortem diagnostics tests are required for earlier 
detection of infected individuals to prevent intra- and inter-species transmission and develop 
control programs (Kaneene et al. 2010, Michel et al. 2006). 
Currently used diagnostic tests for bTB in cattle rely on the detection of cell-mediated 
immunity (CMI) to M. bovis antigens. The primary ante-mortem test, the single intradermal 
comparative tuberculin test (SICTT), measures a delayed type hypersensitivity (DTH) response 
to mycobacterial antigens, specifically M. bovis purified protein derivative (PPD-B) and M. 
avium-PPD (PPD-A). The test relies on the measurement of dermal inflammation three days 
after intradermal injections in the skin of the caudal fold (CFT) or neck (SICTT). A difference 
in skin thickness of 4mm or more at the PPD-B injection site compared to the PPD-A site is 
considered definitively positive while a measurement of between 2mm and 4mm is a suspected 
positive result (Schiller et al. 2010). The advantages of the skin test are its low cost and high 
availability. However, this test has been shown to lack both sensitivity and specificity (Schiller 
et al. 2010, Rothel et al 1990). It also requires that the animals are handled twice and the test 
cannot be repeated for approximately 90 days because of immunological sensitization to the 
PPD antigens. Movement of animals require that all individuals test negative on successive 
skin tests, therefore a long waiting period between re-testing can delay the whole procedure 
(Rothel et al 1990). 
An alternative to the SICTT is the interferon gamma release assay (IGRA), an in vitro 
diagnostic test that quantifies the secretion of interferon gamma (IFN-γ) by lymphocytes in 
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response to pathogen-specific antigen stimulation. IFN-γ in the plasma supernatant is 
quantified in a sandwich enzyme-linked immunosorbent assay (ELISA) using detection 
antibodies specific to the species of interest (Schiller et al. 2010). This assay is significantly 
more sensitive than the SCITT and results can be produced within 24 hours (Wood et al., 1990). 
Commercially available IFN-γ ELISA based tests such as the BOVIGAM® (Prionics, 
Switzerland) have come onto the market as ancillary tests for bTB detection in cattle (Bass et 
al. 2013). Limitations of the IFN-γ assay are reduced specificity, high cost and high logistical 
demands (Vordermeier et al. 2006, de la Rua-Domenech et al. 2006). IGRAs also require that 
species-specific antibodies are used for the detection of IFN-γ, thus they have only been 
developed for a few select species including: European badger (Cousins and Florisson, 2006), 
African buffalo (Grobler et al. 2002), domestic cattle (Wood et al. 1991), red deer (Slobbe et 
al. 2000), and pigs (Cousins and Florisson, 2006). More recently the specificity of IGRAs has 
been improved by using antigens specific to M. bovis, such as 6 kDa early secretory antigenic 
target (ESAT-6) and the 10 kDa culture filtrate protein (CFP-10), which are both highly 
expressed by M. bovis (Vordermeier et al. 2001). This has led to the development of the 
modified QuantiFERON TB-Gold (mQFT) assay, an adapted version of a human TB test, 
which has been described for the testing of buffaloes (Parsons et al. 2011).  
Detection of additional biomarkers involved in the antigen–specific immune response to M. 
bovis has the potential to significantly increase the sensitivity and specificity of bTB diagnostic 
tests. The discovery of novel biomarkers for use in animal studies is aided by the identification 
of candidate targets studied in human tuberculosis patients (Ruhwald et al. 2009). Recently, a 
candidate biomarker, interferon gamma-induced protein 10 (IP-10) was identified as an 
alternative to measuring IFN-γ release in a cohort of M. bovis exposed African buffaloes, with 
the potential for increased sensitivity over conventional IGRAs (Goosen et al. 2015). Another 
candidate biomarker identified previously, monocyte chemoattractant protein-1 (MCP-1), was 
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shown to have promise as a diagnostic marker for M. bovis infection in African buffaloes. This 
chemokine was also found in far greater abundance in antigen-stimulated plasma of infected 
buffaloes compared to human patients with TB (Goosen et al. 2014). MCP-1, a member of the 
C-C chemokine family, is involved in recruiting monocytes, memory T lymphocytes, and 
natural killer (NK) cells to sites of infection. It is mainly produced by monocytes and 
macrophages in response to oxidative stress, cytokines or growth factors released during an 
inflammatory response (Deshmane et al. 2009). MCP-1 has also been shown to be essential in 
the formation of granulomas and provides protection against tuberculosis in the mouse model 
via recruitment of antigen specific T-lymphocytes to the infected tissue (Kipnis et al. 2003). In 
a study of human tuberculosis patients, MCP-1 had a higher sensitivity and specificity for 
diagnosing active tuberculosis compared to IFN-γ and was useful in differentiating between 
active and latent tuberculosis (Wang et al. 2015). 
bTB is characterized by a predominantly cell-mediated response during the early and 
intermediate stages of infection with a humoral (antibody-mediated) immune response 
appearing later in the course of infection (Ritacco et al. 1991). CMI or T-helper type-1 (Th1) 
responses involve macrophages, dendritic cells and an adaptive T-cell response, and are 
controlled by cytokines released from antigen-specific T-cells. The result of the CMI response 
is the formation of the granuloma in which bacteria are walled off to prevent their spread.  A 
significant biological challenge to the host immune response is a balance between the 
antimicrobial activity needed to kill the pathogen while at the same time limiting its own tissue 
damage. T-helper type-2 (Th2) responses are required to inhibit Th1 responses in order to limit 
physiological damage but they can also contribute to pathology. Th1 cells enhance cell 
mediated immunity and are the primary source for the inflammatory cytokines IFN-γ, 
interleukin (IL)-2, tumour necrosis factor (TNF)-α and TNF-β, which are involved in the 
activation of macrophages and lymphocytes for the destruction of bacterial pathogens 
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(Romagnani et al. 2000). Th2 cells activate and maintain the humoral immune response by 
producing various cytokines such as IL-4, IL-5, IL-10 and IL-13. Th2 cytokines are responsible 
for inducing strong antibody responses, eosinophil activation and inhibition of several 
macrophage functions (Romagnani et al. 2000, Gu et al. 2010). Studies have shown that during 
the course of infection, cattle may convert from a Th1 response to a Th2 response and this 
conversion is associated with increased pathology (Hernández-Pando et al. 1996, Thacker et 
al. 2007). It has been reported that antibody responses to M. bovis infection correlate with 
disease pathology, likely due to increased antigen burden (Harboe et al. 1990, Lyashchenko et 
al. 2004). In cases of advanced tuberculosis, cattle may become immunologically anergic; these 
animals lack a measureable CMI response but can have high circulating antibody levels (Neill 
et al. 2001). Therefore, diagnostic tests such as IGRAs that rely on the detection of Th1 
cytokines may be more useful for identifying animals in the early stages of infection, whereas 
antibody based diagnostics or tests detecting cytokines involved in the Th2 response could be 
used to identify animals at a more advanced stage of disease (Ritacco et al. 1991). Other 
advantages of serological diagnostic tests include the rapidity in which responses can be 
detected as well as the stability of antibodies during transport and storage (Green et al. 2009, 
Lyashchenko et al. 2013).  
MCP-1 plays a critical role in the polarization of Th0 cells towards a Th2 phenotype by 
stimulating the production of IL-4. This also inhibits the production of pro-inflammatory (Th1) 
IFN-γ-secreting cells (Gu et al. 2000). Th2 activation induces the proliferation of antibody 
producing B-cells and is required for immunoglobulin subclass switching, therefore mice 
deficient in MCP-1 are unable to mount effective Th2 responses (Gu et al. 2000). Due to its 
ability to attract monocytes, MCP-1 is thought to have a pathobiological role in inflammatory 
disorders and high levels of MCP-1 in infected animals may therefore represent a sign of 
pathology or advanced stages of disease (Kipnis et al. 2003). The role of this cytokine in Th2 
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activation and its association with pathology make MCP-1 a promising biomarker in the 
investigation of the immune response to M. bovis infection in African buffalo. 
The ELISA technique is used to measure the binding of antibodies to antigen fixed on a solid-
phase adsorbent, such as a polystyrene microtitre plate. An ELISA which detects antibodies 
against M. bovis was reported in 2008 for wild boar with a sensitivity and specificity of 73% 
and 96%, respectively (Aurtenetxe et al. 2008). Another technique used for the detection of 
antibodies to mycobacterial antigens is the multi-antigen print immunoassay (MAPIA). The 
MAPIA consists of a cocktail of antigens immobilized on a nitrocellulose membrane in narrow 
strips.  The membrane is incubated with test sera and antibody-antigen complexes are visually 
detected (Lyashchenko et al. 2000). Using this method, antibodies against multiple antigens 
can be screened in a single serum sample. Advantages of the MAPIA over the ELISA technique 
include an efficient and cost effective method for screening antibodies to many antigens, high 
versatility and the potential to evolve into a rapid point-of-care diagnostic (Lyashchenko et al. 
2000). The poor sensitivity of serological tests has slowed the widespread use of these assays 
for early detection of bTB in cattle. Reports have shown that not all cattle with tuberculous 
lesions have a detectable antibody response, however this seems to vary between species as 
serological tests for bTB in elephants and wild boar have reported greater sensitivities, i.e. 
100% and 89.6%, respectively (Boadella et al. 2011, Lyashchenko et al. 2006).  
Several new serological tests with more promising accuracy have recently emerged (Green et 
al. 2009, Waters et al. 2011). The Chembio DPP VetTB® assay is an example of a 
commercially available test designed to measure antibody responses to M. bovis specific 
antigens. The DPP VetTB® assay utilizes a two-step process aimed at rapid detection of 
specific antibodies and has been validated for use in animal species including red deer (Buddle 
et al. 2010), white-tailed deer (Lyashchenko et al. 2013), African and Asian elephants 
(Greenwald et al. 2009). The membrane strip contains two test antigen bands, T1 (MPB83 
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protein) and T2 (ESAT-6/CFP-10 fusion protein), which allows differential immunoglobulin 
G (IgG) antibody detection. Species-nonspecific detection occurs by binding of colloidal gold 
particles coupled to recombinant protein A/G with the antigen-antibody complexes fixed to the 
membrane (Lyashchenko et al. 2013).  Another rapid serological diagnostic test, the Chembio 
STAT-PAK, first used in 2003 for the detection of bTB in Eurasian badgers, has become a 
popular tool for the serodiagnosis of bTB in a variety of wildlife species (Greenwald et al., 
2003).  The STAT-PAK detects antibodies to a cocktail of M. bovis antigens and results can be 
provided in 20 minutes. The test is validated for use in elephants (Lyashchenko et al. 2006) 
and cervids (Gowtage-Sequeira et al. 2009), although it is not currently available.  
 
Quantitative real-time Polymerase Chain Reaction (qPCR) is an additional technique which 
can be used to investigate the gene expression of cytokines involved in the Th2 immune 
response to M. bovis infection. Therefore, helping us to better understand the complex 
interactions which occur between host and pathogen (McGuire et al. 2005). Genes involved in 
the immune response may be either up- or down-regulated during microbial infection, therefore 
studying gene expression in combination with protein secretion could help better characterize 
the immune status of the animal. Targeted immuno-specific bovine cDNA microarray analysis 
has been used to study the gene expression profile of M. bovis infected cattle (Meade et al. 
2006, Meade et al. 2007, MacHugh et al. 2009, Lim et al. 2012). In a study evaluating the 
expression of 1336 genes, 244 were differentially expressed between antigen-stimulated and 
non-stimulated peripheral blood mononuclear cells (PBMC) with the majority (137) of those 
genes showing significant down-regulation (Meade et al. 2006). Meade et al. (2007) 
investigated differences in gene expression of ex vivo PBMC between M. bovis infected cattle 
and healthy cattle, without in vitro antigen stimulation. Their results confirmed earlier findings 
and showed that out of 378 genes identified as differentially expressed between the two groups, 
244 (65%) of those genes were down-regulated. These variations can provide a gene expression 
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profile which may be useful to the characterization of the immune response to M. bovis 
infection and lead to the development of improved diagnostics and/or vaccines (Thacker et al. 
2007). Parsons et al. (2011) developed a diagnostic gene expression assay for the detection of 
M. bovis infected African buffalo using cDNA from antigen-stimulated whole-blood samples. 
The IFN-γ gene was significantly upregulated in antigen-stimulated samples from bTB-
positive buffalo compared to bTB-negative buffalo. Furthermore, they were able to distinguish 
between the two groups with a sensitivity and specificity of 80% and 95%, respectively 
(Parsons et al. 2011).  
qPCR is a highly sensitive and accurate technique for the quantification of mRNA transcripts 
and has become the method of choice for measuring changes in gene expression levels. The 
relative quantification method for qPCR gene expression analysis is preferred over absolute 
quantification when the absolute copy number of mRNA is not required (Bustin et al. 2000, 
Pfaffl et al. 2001). In relative quantification, the expression of your gene/s of interest is 
calculated in relation to a reference gene subjected to the same experimental conditions. The 
assumption is that the reference gene(s) is expressed constitutively and therefore the levels of 
expression remain the same between sample types and under different experimental treatments 
(Bustin et al. 2000, Hugget et al. 2005). Reference genes such as glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) and beta actin (ACTB) have been commonly used in early gene 
expression studies, however, a number of studies have shown that expression of reference 
genes is influenced by sample type and experimental treatments (Ronbinson et al. 2007, 
Varshney et al. 2012, Lisowski et al. 2008). It is therefore a necessary prerequisite to 
appropriately validate reference genes under specific experimental conditions before they can 
be used for accurate gene quantification. Previous studies evaluating gene expression in cattle 
were referred to for a selection of commonly used reference genes (Vorachek et al. 2013, 
Lisowski et al. 2008, Varshney et al. 2012). The 8 reference genes selected were: GAPDH, 
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ACTB, Beta-2-Microglobulin (B2M), Tyrosine 3-monooxygenase/tryptophan 5-
monooxygenase activation protein, zeta (YWHAZ), Peptidylprolyl isomerase A (PPIA), H3 
histone, family 3A (H3F3A), TATA-binding protein (TBP), and Hypoxanthine 
phosphoribosyltransferase 1 (HPRT1).  Software programs such as geNorm (Vandesompele et 
al. 2002) and NormFinder (Andersen et al. 2004) have been developed which use different 
algorithms to assess the stability of candidate reference genes. Using multiple reference genes 
in the analysis can improve the accuracy of quantification (Vandesompele et al. 2002). Further 
optimization of gene expression assays could provide useful tools for characterizing the gene 
expression profile in M. bovis infected animals and lead to the development of more sensitive 
diagnostic tests for bTB. 
 
In summary, bTB is a chronic disease that is maintained by free-ranging wildlife reservoirs 
such as the African buffalo with the potential to spill-over to livestock, other wildlife species, 
and even humans. Diagnostic tools offering accurate and rapid detection of infected animals 
are required to effectively monitor and develop management strategies for bTB in wild 
populations. Currently available diagnostic tests have been shown to lack the sensitivity 
required when testing for bTB in certain species. False negative animals may result in 
introduction of disease into new areas when translocated, or perpetuate infection in current 
locations. Serological diagnostic tests show promise for detecting infected animals which may 
be missed by conventional CMI based tests, especially in advanced disease.  Although humoral 
responses appear to correlate with disease pathology, they are known to lack sensitivity in 
certain species. Therefore, characterization of the immune response to bTB can help identify 
potential targets that when incorporated into novel diagnostics, will improve the detection of 
M. bovis infected animals.  
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The present study aimed to develop an in-house ELISA for the detection of antibodies against 
M. bovis antigens in order to evaluate the humoral immune response in bTB-positive African 
buffalo. Secondly, MCP-1, which plays a role in stimulating the antibody-mediated immune 
response to infection, was evaluated as a diagnostic biomarker of disease in buffalo. In addition, 
expression stability of 8 reference genes was determined for potential use in a gene expression 
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Chapter 2 - Literature review: 
 
The dominant immunogenic proteins of Mycobacterium bovis: 




Mycobacterium bovis is part of the Mycobacterium tuberculosis complex (MTC), a genetically 
related group of bacteria that can infect and cause tuberculosis in a wide range of mammal 
species, including humans (Michel 2008). During the course of microbial infection, various 
molecules (proteins) associated with the causative organism are recognized by cells of the 
immune system (Fifis et al. 1994). This leads to a complex cascade of immune responses which 
can be measured using several techniques. Some proteins are more capable than others of 
inducing an immune response in the host, due to certain biological traits such as the amount of 
protein secreted or its chemical complexity, collectively referred to as the immunogenicity 
(Hewinson et al. 1996). Proteins with high immunogenicity are therefore important potential 
targets for use in diagnostic tests for infectious diseases such as tuberculosis. A family of highly 
immunogenic proteins derived from mycobacteria are the so-called MPB and MPT proteins. 
The term ‘MPB’ is used to refer to proteins produced by M. bovis, while ‘MPT’ refers to 
proteins from the closely related species M. tuberculosis. The numbers 70 and 83 relate to the 
relative mobility of 0.70 and 0.83 by native polyacrylamide gel electrophoresis at pH 9.4. 
MPB70 was first purified from culture filtrates of M. bovis BCG and it was subsequently found 
to elicit a delayed type hypersensitivity (DTH) response in guinea pigs sensitized with certain 
BCG strains but not by other BCG strains or members of the Mycobacterium tuberculosis 
complex (MTC) (Nagai et al. 1981, Miura et al. 1983). Antibody responses to MPB70 were 
found to follow a very similar pattern among these strains (Hasløv et al. 1987). Further analyses 
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using radioimmunoassay inhibition test showed the presence of MPB70 in the BCG strains that 
induced DTH however, it was found to be in very low amounts in strains unable to induce this 
response (Harboe and Nagai 1984, Hasløv et al. 1987). These studies formed the basis for 
dividing BCG strains and other mycobacteria into the two main groups now known as MPB70 
high producers and MPB70 low producers. It was discovered that low levels of MPB70 were 
found in sonicated extracts from whole washed mycobacterial cells, indicating this protein was 
actively secreted from the cells. These findings were supported by the observation that large 
amounts of heat killed BCG Tokyo cells induced very low level of DTH compared to small 
doses of live BCG Tokyo (Miura et al. 1983).  
Early knowledge of MPB83 was limited by the lack of genomic data and because the protein 
had not yet been purified. Bands in western blotting thought to be glycosylated MPB70 were 
actually MPB83, and the relationship between these products was shown using a monoclonal 
antibody which strongly recognized both proteins (Fifis et al. 1992, Wiker et al. 1996). MPB83 
was later isolated and purified to near homogeneity from M. bovis BCG Tokyo culture filtrate 
by Harboe et al. (1995). In the same study they were able to show that peptides of MPB83 
isolated after cyanogen bromide cleavage had widespread homology as well as distinct 
variations in the amino acid sequence compared to that of MPB70 (Harboe et al. 1995, Terasaka 
et al. 1989). Guinea pigs sensitized with live BCG Tokyo also developed a DTH response to 
intradermally injected MPB83 (Harboe et al. 1995). Further characterization of these proteins 
was required in order to determine their potential value for the diagnosis of bovine tuberculosis.  
 
2.2 Properties of MPB70 and MPB83 
 
There are two genes encoding the proteins MPB70 and MPB83 that lie within an operon of six 
genes, with the gene of mpb83 (Mb2898) located approximately 2.3kb upstream of mpb70 
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(Mb2900)  (Matsuo et al. 1996, Radford et al. 1990). The orthologs of mpb83 and mpb70 found 
in M. tuberculosis, mpt83 and mpt70, are 100% identical at the sequence and amino acid level 
(Wiker et al. 1998, Hewinson et al. 1996). Both genes encode pre-proteins containing typical 
hydrophobic signal peptides which are cleaved following translocation. Cloning and 
sequencing of mpb70 revealed a mature protein of 163 amino acids in length and a signal 
peptide at the N-terminus consisting of 30 amino acids (Terasaka et al. 1989, Radford et al. 
1990). In later studies when mpb83 was cloned and sequenced, it was discovered to code for a 
200 amino acid mature peptide with an N-terminal signal peptide of 20 amino acids (Matsuo 
et al. 1996). Although the sequence and size of signal peptides between the two proteins are 
quite different, there is high homology, around 73%, within regions of the mature protein 
(Matsuo et al. 1996, Wiker et al. 1998). Both the nucleotide and amino acid sequences for 
MPB70 and MPB83 were later confirmed when the complete genome of M. bovis was 
published in 2003 (Garnier et al. 2003). 
The molecular mass (kDa) of both proteins are very similar as judged by sodium dodecyl 
sulphate-polyacrylamide gel electrophoresis (SDS-PAGE); however, the isoelectric points (pI) 
of MPB70 (pI = 4.8) and MPB83 (pI = 4.7) are slightly different (Harboe et al. 1995, Wiker et 
al. 1998). MPB70 migrates with an apparent molecular mass of 22 kDa under reduced 
conditions with mercaptoethanol (ME) and 15 kDa when unreduced (Wiker et al. 1998). The 
native MPB83 protein has a molecular mass of 23 kDa when reduced with ME and 22 kDa in 
unreduced conditions (Hewinson et al. 1996, Wiker et al. 1998). Both proteins contain two 
cysteine residues which are widely separated and the formation of internal disulphide bridges 
between these cysteines produces rings structures in both proteins. These disulphide bridges 
alter the three-dimensional (3D) structure of the molecules and can therefore influence the 
speed at which the peptides migrate in SDS-PAGE (Wiker et al. 1998). The internal disulphide 
bridges that were predicted by SDS-PAGE have been confirmed for MPB70 after its 3D 
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structure was determined by NMR spectroscopy (Carr et al. 2003). The 3D structure of MPB83 
has not yet been determined.  
Before the identification of MPB83 as a distinct protein to MPB70, a 25 kDa band in SDS-
PAGE was observed to be recognized by monoclonal antibodies against MPB70. It was 
discovered that this protein was also glycosylated and it was therefore reported as being a 
glycosylated form of MPB70 (Fifis et al. 1991). The 25 kDa antigen was subsequently purified 
and the amino acid sequence revealed this was a protein encoded on a separate gene to mpb70 
(Harboe et al. 1995), thus proving that the 25 kDa antigen is a glycosylated form of the 23 kDa 
MPB83 protein. A unique difference of mature MPB83 compared to MPB70 is the presence of 
a classic lipoprotein motif as well as a unique amino acid insert of 25 peptides in its N-terminus 
containing a glycosylation site (Hewinson et al. 1996, Vosloo et al. 1997). Biochemical and 
structural analysis of MPB83 demonstrated that this protein is O-glycosylated with mannose 
via threonine residues. Three mannose units were found attached to two threonine residues 
approximately 25 residues from the N-terminal region of the mature peptide (Michell et al. 
2003). Mannose residues were joined by 1 → 3 linkages, in contrast to the 1 → 2 linkage 
previously described for the antigen MPB32 (Dobos et al. 1996). The 23 kDa unglycosylated 
form is not observed when mpb83 is cloned into M. smegmatis. This may suggest that M. bovis 
has peptidases involved in post-translational modification which are not found in other non-
pathogenic mycobacteria (Michell et al. 2003). The exact role of these glycosylations is unclear 
although it has been proposed that they protect lipoproteins from cleavage in the N-terminal 
region which is vulnerable to proteolytic cleavage (Dobos et al. 1996). 
MPB70 has been shown to be highly soluble and present in large amounts in the culture filtrate 
of M. bovis or BCG high producing strains. However, when protein extracts are prepared from 
bacterial cells prewashed with an aqueous buffer, MPB70 is barely detected (Wiker et al. 1991). 
This demonstrates that MPB70 is actively secreted into the culture medium when cells are 
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grown in liquid media and are therefore not associated with the cell surface. In contrast, using 
flow cytometry and monoclonal antibodies against MPB83, it was shown that this protein was 
found on the surface of M. tuberculosis complex cells and anchored to the cell wall via the N-
terminal lipid group (Harboe et al. 1998). The purified native 23-kDa MPB83 molecule is also 
a soluble secreted (nonlipoprotein) variant of the 26-kDa lipoprotein. 
 
2.3 Differential expression of MPB70 and MPB83 
 
A key phenotypic difference between M. bovis and M. tuberculosis is in the production of the 
proteins MPB70 and MPB83. M. bovis has a high level of expression for these proteins in vitro 
whereas their production in M. tuberculosis is very low (Harboe and Nagai 1984, Hewinson et al. 
1996). Later findings showed that all MTC members tested (M. tuberculosis, M. africanum, M. 
microti), were low producers of MPB70 compared to M. bovis (Liebana et al. 1996). Also, levels 
of MPB70 and MPB83 expression varied between different strains of BCG (Table 1) (Wiker et al. 
1996). BCG strains obtained from the Pasteur Institute before 1927 have high levels of MPB70 
and MPB83 production, while strains obtained after 1931 have much lower production, most likely 
due to in vitro mutations during this period (Behr and Small. 1999, Charlet et al. 2005). The pattern 
of MPB70 high- and low-producing substrains of BCG is only partially applicable for MPB83. 
Strains that are MPB70 low producers are also MPB83 low producers, however, the expression of 
MPB83 varies much more than the expression of MPB70 in the MPB70 high-producing strains 
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Table 1 – The production of MPB70 in various strains of M. bovis and other MTC members 
is grouped into high and low producers. 
MPB70 high producers MPB70 low producers 
M. bovis AF2122/97 M. tuberculosis H37Rv 
M. bovis AN5 M. africanum 
M. bovis Ravenel M. microti 
M. bovis 04-303 M. bovis BCG Pasteur 
M. bovis BCG Tokyo M. bovis BCG Copenhagen 
M. bovis BCG Moreau M. bovis BCG Glaxo 
M. bovis BCG Russia M. bovis BCG Beijing 
M. bovis BCG Sweden M. bovis BCG Tice 
 
 
Interestingly, another secreted protein specific to the MTC named MPB64 was found to exhibit a 
similar expression pattern to MPB70 and MPB83 in BCG strains (Harboe et al. 1986, Wiker et al. 
1996). MPB64 is only secreted by M. tuberculosis and M. bovis, and therefore appears to be highly 
specific for these two species (Tamada et al. 2012). High levels of MPB64 in the BCG high-
producing strains correlates with levels of MPB70, suggesting that these genes are partly 
controlled by the same regulatory mechanism (Wiker et al. 1996). However, in the MPB70 low-
producers, MPB64 was not detected at all and it was subsequently shown that the mpb64 gene was 
deleted from all MPB70 and MPB83 low-producing BCG strains (Li et al. 1991). This was the 
first gene deletion discovered in BCG and the results seemed to indicate that the amount of MPB70 
was related to the presence of the MPB64 gene or other factors (Matsuo et al. 1995, Li et al. 1991). 
In contrast, MPB64 is expressed in high levels by M. tuberculosis even though MPB70 and MPB83 
are expressed in low levels when compared to M. bovis and BCG high-producers (Wiker et al. 
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1996). These observations suggest that there is a different mechanism to explain the variable 
expression of these two proteins between mycobacterial species.  
Observed differences in MPB70 and MPB83 secretion between the substrains may be due to 
variance in the coding or non-coding regions of the specific genes. Cloning and sequencing of 
mpb70 and mpb83 showed that there was no difference in nucleotide sequence between the high- 
and low-producing substrains. Furthermore, the upstream and downstream regulatory regions also 
had identical nucleotide sequences (Matsuo et al. 1995, Hewinson et al. 1996). In an attempt to 
explore the underlying differences in protein production, Matsumoto et al. (1995) cloned the 
mpb70 gene from BCG Tokyo (high-producer) into BCG Pasteur (low-producer) but was unable 
to restore levels of MPB70 to those recorded in wild-type BCG Tokyo. Additionally, by targeted 
gene expression analysis using qPCR, differences were seen in the amount of MPB70 mRNA 
produced by each substrain. In BCG Tokyo the mRNA was readily detected, while in BCG Pasteur 
it was found at a very low level (Matsuo et al. 1995). Both these results suggest that the different 
levels of secreted MPB70 observed were due to the efficiency of gene transcription inherent to the 
parent BCG strain.  
BCG strains have accumulated a number of mutations such as single-nucleotide polymorphisms 
(SNPs) and deletions during their half a century of in vitro passage (Behr et al. 1999). Since some 
of these mutations affect known regulatory genes, it was therefore hypothesized that a mutation in 
a regulatory gene was causing the variance in production of MPB70 and MPB83 (Behr et al. 1999, 
Charlet et al. 2005). Using microarray analysis, a genetic region showing consistent down 
regulation in low-producing strains contained the gene for sigma factor K (sigK), a transcriptional 
regulator (Charlet et al. 2005). Subsequently, it was shown that all eight low producing BCG 
strains had the same point mutation in the start codon of sigK. This G → A mutation at the third 
position resulted in a AUA start codon which significantly affected levels of transcription. When 
wild-type sigK from a BCG high-producer was complemented into a low-producing strain the 
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results showed a marked increase in MPB70 and MPB83 protein production, at levels consistent 
with high-producing strains. These results show that sigma factor K positively regulates the 
expression of MPB70 and MPB83 (Charlet et al. 2005).  
The sigK start codon in M. tuberculosis and M. bovis contains the wild-type AUG sequence, even 
though MPB70 and MPB83 are differentially expressed in vitro by these two species. These 
differences were thought to occur due to unregulated activity of sigK in M. bovis. The repressor 
protein, Anti-SigK is coded by the gene Rv0444c which is co-transcribed and lies immediately 
downstream of sigK. Sequencing analysis revealed that Rv0444c in M. bovis contains two non-
synonymous SNPs, C320T and C551T, resulting in a non-functional protein product (Saïd-Salim 
et al. 2006). The sequence was then compared to members of the MTC with low MPB70/MPB83 
production, such as M. tuberculosis H37Rv and M. africanum. All low-producing strains had the 
wild-type sequence for Anti-SigK, indicating that the increased expression of MPB70 and MPB83 
in M. bovis is due to a dysfunctional anti-SigK (Saïd-Salim et al. 2006). The increased expression 
of MPB83 and MPB70 in M. bovis compared to other MTC members means that more specific 
bTB diagnostic tests can be developed, thus eliminating the potential cross-reactivity between 
immunogenic proteins of various pathogenic mycobacteria.  
 
2.4 Immunologic characteristics of MPB70 and MPB83 
 
2.4.1 Monoclonal antibodies 
 
Monoclonal antibodies (mAbs) that bind to MPB70 and MPB83 have been produced by various 
independent groups (Wiker et al. 1998, Wood et al. 1988, Lyashchenko et al. 1993, 
Lyashchenko et al. 2001). In many cases, antibodies have shown strong binding to both 
proteins, providing further evidence of the structural homology between these two proteins 
(Wiker et al. 1998). The antibodies 12/6/1 and SB10 react to shared epitopes of MPB70 and 
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MPB83 and were found to bind to both proteins during western blot analysis (Wiker et al. 
1996).  Importantly, antibodies that bind specifically to only one of the proteins are useful for 
allowing researchers to distinguish between MPB70 and MPB83 (Wiker et al. 1996). Wood et 
al. (1988) produced several mAbs, named the SB series (SB1 - SB10), which were specific to 
antigens in the culture filtrate of M. bovis. These antibodies all bound to culture filtrate proteins 
of M. bovis and BCG while showing minimal cross-reactivity to M. tuberculosis H37Rv 
proteins. The anti-MPB70 antibodies of the SB series were found to be reactive to three 
different molecular species of 20 kDa, 22 kDa and 25 kDa, suggesting possible cross reactivity 
with other antigens (Wood et al. 1988). In a later study, MPB70 was further purified to 
homogeneity and used to produce mouse monoclonal antibodies with high affinity against 
MPB70. The monoclonal antibodies Bov-1, -2 and -3 were found to recognize different 
epitopes of MPB70, therefore indicating the presence of at least 3 binding sites on the protein. 
However, Bov-1 was the most potent mAb and reacted with only a single molecular species in 
the culture filtrate of M. bovis (Haga et al. 1992). More recently, mAbs have been produced 
and described as entirely specific to their corresponding protein, for example MBS43 binds 
specifically to MPB83 whereas 1-5C binds specifically to MPB70 (Wiker et al. 1996, Wiker et 
al. 1998). In a study investigating new antibodies to MPB70 and MPB83, Lyashchenko et al. 
(2001) identified that most mAbs produced against these proteins were of IgG1, IgG2a or 
IgG2b isotypes. They found several antibodies reacted with both proteins, however two new 
mAbs, 1-5A and 3-5C bound exclusively to MPB70. They further showed that these new 
antibodies had identical reactivity to the previously discovered anti-MPB70 antibody 1-5C 
(Lyashchenko et al. 2001). The discovery of novel mAbs is an important step for the 
development of serological assays for bTB. 
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2.4.2 Serological diagnostics 
 
The high expression of MPB70 and MPB83 in M. bovis has led researchers to investigate 
whether antibody responses against MPB70 or MPB83 could be used as an indicator of M. 
bovis infection. One of the first studies was performed using sera from a herd of 44 cattle 
naturally infected with M. bovis using MPB70 as a capture antigen on an ELISA plate. This 
assay reported a sensitivity of 73% and 88% specificity, using histopathological diagnosis as 
the gold standard (Harboe et al. 1990). A number of studies investigating the diagnosis of bTB 
using MPB70 in serological assays reported variable sensitivities (18%-73%), although high 
specificities have been observed (88-96%) (Wood et al. 1992, Sugden et al. 1997, Lyashchenko 
et al. 2000, Cho et al. 2007). Humoral responses are generally low or absent in the first stages 
of the infection period but are known to significantly increase in later stages of disease (Fifis 
et al. 1994). Antibodies against MPB70 have been shown to develop between 18-22 months 
after experimental infection of cattle with M. bovis; in contrast antibodies to MPB83 can be 
detected as early as 4 weeks post-infection (O’Loan et al. 1994, Waters et al. 2006). Low 
sensitivities (37%-37.5%) have also been recorded for serological assays detecting antibodies 
against MPB83, however the specificity (89%-98%) remains high (Goodger et al. 1994, 
McNair et al. 2001). Due to the high specificity achieved using these antigens in serological 
tests, there is still potential for the development of cost effective and specific diagnostic assays 
for the detection of bTB. There is a renewed interest in antibody based diagnostics with recent 
studies showing promising results for detecting infected animals missed by conventional TB 
diagnostics such as the tuberculin skin test (TST) and Interferon Gamma (IFN-γ) Release 
Assays (IGRA) (Koo et al. 2005, Green et al. 2009, Casal et al. 2014). Serological assays using 
MPB83 for the detection of M. bovis infection have now been developed and used in a number 
of different species including cattle, badgers, wild boar, non-human primates and white-tailed 
deer (Liu et al. 2007, Greenwald et al. 2003, Lyashchenko et al. 2007, Lyashchenko et al. 
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2008). Waters et al. (2011) described the performance of the IDEXX M. bovis ELISA (IDEXX 
Laboratories, Inc., Maine, USA) assay which detects antibodies against both MPB70 and 
MPB83 for the diagnosis of bTB in cattle. In this study they reported a sensitivity of 63% and 
a specificity of 98% with samples from naturally infected cattle (Waters et al. 2011). 
Additionally the IDEXX M. bovis ELISA was able to detect antibodies against both proteins 
in milk samples from bulk tanks of M. bovis infected dairy herds (Waters et al. 2011). In a 
separate study, using MPB70 and MPB83 separately as capture antigens in an ELISA, a 
significant difference in antibody response was observed for cattle infected with M. bovis 
compared to those infected with M. avium subsp. paratuberculosis, therefore showing promise 
as a tool to distinguish between these two infections (Marassi et al. 2009). A commercially 
available test produced by Chembio® called the Dual Path Platform VetTB (DPP) (Chembio 
Diagnostic Systems, Inc., NY, USA) uses lateral-flow technology to detect antibodies against 
MPB83 and the fusion protein ESAT-6/CFP-10. The VetTB DPP was found to have a 
sensitivity and specificity of 72% and 98%, respectively, in white-tailed deer naturally infected 
with M. bovis (Lyashchenko et al. 2013). MPB70 and MPB83 both show promising results for 
use as capture antigens, although further research is required to optimize test performance and 
determine the specific value of serological bTB diagnostic tests in different species. The 
availability of rapid serodiagnostic tests for use in a wide range of animal species is important 
for the early detection of M .bovis infection, and because of their relatively high specificity 
they can be used as a screening tool for disease surveillance in wildlife where handling of 
animals presents risks to both the animal and staff. 
2.4.3 Cellular immune response  
 
T-cell responses were characterized during the initial experiments on purification of MPB70 
when it was established that this protein induced a strong skin test reaction in guinea pigs 
sensitized with BCG Tokyo, but not M. tuberculosis (Nagai et al. 1986). The peak of the skin 
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test response to MPB70 was found to be 15 weeks after sensitization of guinea pigs with BCG 
Tokyo (Haslov et al. 1987). The cytokines IFN-γ and tumour necrosis factor-α (TNF-α), both 
involved in the immune response to mycobacterial infections, are induced in vitro in response 
to stimulation of peripheral blood mononuclear cells (PBMC) with MPB70 (Al-Attiyah et al. 
2006). A study by Olsen et al. (2005) showed that natural killer (NK cells) isolated from 
clinically healthy calves produced IFN-γ in response to bovine PPD and ESAT-6 but not to 
MPB70. The IFN-γ response to the MPB70 antigen has been extensively studied for the 
diagnosis of tuberculosis, however, the ESAT-6/CFP-10 mixture has been observed to induce 
a much greater response (Pollock et al. 2000, Al Attiyah et al. 2006, Aangaard et al. 2006). 
Aangard et al. (2006) used MPB70 as a stimulation antigen in a CMI-based whole blood assay 
to detect IFN-γ in TST-positive cattle and cattle from a TB-free herd. Animals from herds of 
different prevalence were tested at three separate sites and the test sensitivity and specificity 
was determined to be 5%, 56%, 36% and 90%, 100%, 83%, respectively (Aangard et al. 2006).  
Although the T-cell response to MPB83 is less well characterized than that of MPB70, early 
studies showed that intradermally injected MPB83 induced a DTH response in guinea pigs 
sensitized with live BCG Tokyo (Harboe et al. 1995). MPB83 was shown to induce a stronger 
IFN-γ response in whole-blood cultures compared to MPB70 in 10 cattle that were TST-
positive.  In the same study MPB83 was able to differentiate between infected cattle and cattle 
vaccinated with BCG Pasteur (Vordermeier et al. 2000). MPB70 and MPB83 induced a low 
and moderate proliferative response, respectively, in stimulated PBMC from skin test positive 
cattle, however the response induced by ESAT-6 was much greater (Vordermeier et al. 1999). 
These results were confirmed by another group who evaluated the T-cell response in 
experimentally infected cattle to a panel of mycobacterial antigens including PPD, ESAT-6, 
MPB70 and MPB83. Although cell proliferation and release of IFN-γ was induced in PBMCs 
stimulated with MPB70 and MPB83, the responses to ESAT-6 and PPD were higher (Rhodes 
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et al. 2000). Therefore, due to low sensitivity, neither MPB70 nor MPB83 has the potential for 
use in a single-antigen-based diagnostic assay, but they have shown promise when included in 
protein cocktails. Using a protein cocktail composed of ESAT-6, MPB64, and MPB83 to 
stimulate the proliferation of PBMC, researchers were able to differentiate between animals 
that were TST-positive and those vaccinated with BCG (Vordermeier et al. 1999). In another 
study, a cocktail consisting of ESAT-6, CFP-10, MPB70 and MPB83 administered via 
intradermal injection elicited a DTH response in 78% of TST-positive cattle naturally infected 
with M. bovis. Additionally, this protein cocktail was highly specific and no DTH response 
was induced in naïve or BCG-vaccinated calves (Whelan et al. 2010). Both MPB70 and 
MPB83 appear to have poor IFN-γ inducing capabilities compared to ESAT-6 and CFP-10, 
however, when they were included in the skin test cocktail, skin test responder frequency 
increased from 3/12 using only ESAT-6 and CFP-10, to 6/12 (Whelan et al. 2010). These 
results suggest that the use of multi-antigen cocktails containing different immunogenic 
proteins can increase detection of bTB in cattle. 
2.4.4 T-cell epitopes 
 
In order to identify new candidate peptides for antigen stimulations or sub-unit vaccines it is 
crucial to identify the epitopes recognized by T-cells. Linear T-cell epitopes to MPB70 were 
mapped using thirteen 25-mer synthetic peptides with a 10 amino acid overlap, covering the 
entire protein sequence. The peptides showing the strongest responses in the PBMC 
proliferation assay were peptides 8, 12 and 13, which correspond to amino acids (AA) 106-
130, 166-189 and 180-193, respectively (Al Attiyah et al. 2003). The same peptides were found 
to induce the strongest IFN-γ response after stimulation of PBMC from BCG-vaccinated 
healthy subjects (Al Attiyah et al. 2003).  Proliferation assays of PBMC from M. bovis 
experimentally infected cattle demonstrated the immunogenicity of the MPB70 peptides at AA 
118-135 and 174-193 which correspond to peptides 8 and peptide 13 of the previous study. 
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These peptides showed reactivity to naturally infected cattle that were TST-positive, however 
they were not recognized by non-infected controls (Pollock et al. 1994). These results were 
further confirmed by two separate studies. Lightbody et al. (1998) found strong T-cell epitopes 
in AA 81-100 and 171-193 in both MPB70 immunized cattle and cattle experimentally infected 
with M. bovis, whereas Tollefsen et al. (2002) discovered the middle (AA 75-140) and C-
terminal (AA 160-193) regions contained epitopes which induced a cellular response in 
immunized mice. T-cell epitopes to the MPB83 antigen are less well characterized however 
they have been described. Vordermeier et al. (2000) assessed T-cell proliferation in response 
to peptide stimulation in cattle experimentally infected with M. bovis and field TST-positive 
cattle, and found that more than half of the animals reacted to peptides 20, 21 and 22 which 
correspond to the amino acids 184-205, 195-214, 204-225, respectively. More recently it was 
shown that MPB83 has Th1 cell epitopes scattered throughout the protein sequence, however, 
the three peptides that induced the strongest responses were amino acids 151-175, 166-190 and 
196-220 (Mustafa et al. 2011). The first vaccine study in cattle using a DNA vaccination 
expressing either MPB70 or MPB83 showed that all calves, vaccinated with the MPB83 
expressing plasmid, demonstrated a strong Th1 response characterized by IFN-γ release, 
whereas the response to vaccination with MPB70 was less effective. Importantly, the 
specificity of the skin test was not compromised (Vordermeier et al. 2000). The protective 
effect of MPB70 and MPB83 DNA vaccinations prior to intratracheal challenge with M. bovis 
has been investigated, however it was determined that the cattle were not protected from 









The extensive studies performed on these two proteins have identified them as highly 
immunogenic and specific protein targets for the detection of M. bovis infection in a variety of 
animals. Although their use in CMI based diagnostic assays has shown a lack of sensitivity 
when compared to ESAT-6 or CFP-10, serological assays using either one or a combination of 
MPB70 and MPB83 have shown promise as a highly specific diagnostic tool for the rapid 
detection of M. bovis infection. Further studies are required to evaluate the immunogenicity 
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Chapter 3 - Materials and Methods: 
3.1 Animals 
 
African buffaloes were captured and tested between 2011 and 2015 in the Hluhluwe-
iMfolozi Park, Kwazulu-Natal, South Africa, as part of an ongoing bTB control 
program. Animals were chemically immobilized as previously described (Parsons et al. 
2011) and subjected to the Single Comparative Intradermal Tuberculin Test (SCITT) 
as described below. During immobilization, whole-blood (WB) was drawn into 
heparinised blood collection tubes and serum tubes (both BD Biosciences, New Jersey, 
USA) via venipuncture of the jugular vein. Serum tubes were centrifuged at 3000 x g 
for 10 min after which the serum fraction was aliquoted into cryovials and stored at -
20°C. Buffalo were defined as bTB-positive if they tested positive based on the SCITT 
and one ancillary interferon gamma (IFN-γ) release assay (IGRA) as described below 
(3.2), i.e. either the modified QuantiFERON® TB-Gold (mQFT) (Qiagen, Venlo, 
Limburg, Netherlands) or the Bovigam® assay (Prionics, Schlieren-Zurich, 
Switzerland). Animals that tested negative for both the SCITT and IGRA were defined 
as bTB-negative. Ethical approval for this study was granted by the Stellenbosch 
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Skin fold thickness (SFT) was measured at injection sites using Hauptner calipers 
(Kyron Laboratories, Benrose, South Africa). Thereafter, 0.1 ml (50 000 IU) M. bovis 
purified protein derivative (PPD-B) and 0.1 ml (25 000 IU) M. avium PPD (PPD-A) 
(both WDT, Hoyerhagen, Germany) were injected intradermally on either side of the 
neck. The SFT measurements were repeated after 72 hours in all animals with palpable 
inflammation at injection sites. Animals with an increase in SFT of 2 mm or greater at 
the M. bovis PPD injection sites compared to the M. avium PPD injection sites were 




One ml of heparinized whole blood (WB) from each animal was transferred into a QFT-
TB Antigen tube (containing ESAT-6, CFP-10 and TB7.7 peptides) and a QFT-Nil tube 
(containing saline) (Qiagen, Venlo, Limburg, Netherlands). The tubes were shaken 
before incubation at 37°C for 20 hours after which they were centrifuged at 3000 x g 
for 6 minutes and the plasma fraction transferred into a second tube and stored at -80°C. 
The remaining cell pellet was resuspended in 1.3 ml RNAlater® (Ambion, California, 
USA). Plasma harvested from the QFT tubes was used in an in-house IGRA (mQFT 
assay) utilizing a commercial bovine IFN-γ ELISA kit (Mabtech AB, Nacka Strand, 
Sweden) to quantify the concentration of IFN-γ. An animal was defined as mQFT-
positive if the IFN-γ concentration in the plasma of the TB tube was 66pg/ml or more 
greater than in plasma from the Nil tube (Parsons et al. 2011).  
 





Two-hundred and fifty (250) µl of WB was added to each of four 2 ml microcentrifuge 
tubes (Eppendorf, Hamburg, Germany) containing 25 µl solutions of PPD-B (Prionics, 
Schlieren-Zurich, Switzerland) (at a final concentration of 24 µg/ml), PPD-A (Prionics, 
Schlieren-Zurich, Switzerland) (at a final concentration of 24 µg/ml), filter-sterilized 
phosphate buffered saline (PBS) and Pokeweed mitogen (PWM) (Sigma-Aldrich, St. 
Louis, MO,USA) (at a final concentration of 5 µg/ml), respectively. Following 
incubation at 37°C for 20 hours, tubes were centrifuged at 2000 x g for 10 min and the 
plasma fraction transferred to a separate tube and stored at -80°C. All further analyses 
were done according to the manufacturer’s instructions. 
 
3.2.4 Peptide stimulation for MCP-1 
 
One ml WB was added to six 2 ml microcentrifuge tubes (Eppendorf, Hamburg, 
Germany) which contained 20 µl of either saline (Nil), a 1 µg/µl solution of Keyhole 
Limpet Hemocyanin (KLH) peptides (Amino acid sequence: 
WQALQEKRGLPSDRAD (BIOPEP, Stellenbosch, South Africa) diluted in PBS and 
another diluted in 0.1% Dimethyl sulfoxide (DMSO), a 1 µg/µl solution of Bovine 
serum albumin (BSA) peptides (Amino acid sequence: KYLYEIARRHPYFYAPELL) 
(BIOPEP, Stellenbosch, South Africa) diluted in PBS and another diluted in 0.1% 
DMSO, and lastly a 0.1% solution of DMSO in PBS. The tubes were gently agitated 
and incubated at 37°C for 20 hours. Hereafter, tubes were centrifuged at 2000 x g for 
10 min and the plasma fraction transferred to a separate tube. Plasma samples were 
stored at -80°C until tested. DMSO was used as a solvent to dissolve the peptides, a 
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control condition using DMSO alone was included to evaluate its effect on MCP-1 
induction. 
 
3.3 Serological assays 
 
3.3.1 PPD ELISA 
 
Flat-bottomed 96-well microtitre plates (Nunc, New York, USA) were coated with 100 
µl of  a 10 µg/ml PPD-B solution (Prionics, Schlieren-Zurich, Switzerland) in 0.05M 
carbonate-bicarbonate buffer (pH 9.6) and incubated overnight at 4°C. For each well 
coated with antigen a corresponding control well was coated with blocking buffer (BB) 
consisting of 5% milk powder (Clover, Roodepoort, South Africa) in PBS + 0.05% 
Tween-20 (Sigma-Aldrich, St. Louis, MO, USA). After incubation, plates were 
decanted and washed five times with PBS containing 0.05% Tween-20, then blocked 
with 200 µl/well of BB for 1 hour at room temperature (RT). The plates were washed 
as above and either serum or plasma samples diluted 1:200 in BB were added to 
duplicate wells (100 µl/well). Plates were incubated at RT for 1 hour and then washed 
five times as above. Plates were then incubated with 100 µl/well of peroxidase-
conjugated recombinant protein A/G (Thermo Scientific, MA, USA) diluted 1:100 000 
in PBS, for 1 hour at RT. Plates were washed as above before addition of 100 µl/well 
of the colorimetric substrate 3,3’,5,5’-tetramethylbenzidine (TMB) (BD Biosciences, 
New Jersey, USA) and subsequently incubated in the dark for 15 minutes. The reaction 
was stopped using 50 µl/well of 2M H2SO4 and the optical density (OD) of each well 
was measured at 450nm using a LT-4000 Microplate Reader (BMG Labtech, Vienna, 
Austria). For each animal, an assay result was calculated as the mean OD value of the 
PPD-coated wells minus that of the BB-coated wells. The PPD ELISA was used as a 
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measure of antibody levels only and not as a diagnostic, therefore no positive threshold 
was calculated. 
 
3.3.2 Dual Path Platform (DPP) VetTb® assay 
 
The assay was performed according to the manufacturer’s instructions as follows: 5 µl 
of serum or plasma was added to the sample well followed by 2 drops of buffer. After 
5 minutes, 4 drops of buffer were added to the conjugate well. After 15 minutes the test 
results were read, animals were classified as antibody-positive if there was a visible line 
present on either band, while those with no visible line were classified as antibody 
negative. A DPP optical reader device (Chembio Diagnostic Systems Inc., USA) was 
used to measure the reflectance of test strips and a result was quantified as a numerical 
score, represented as reflectance units (RU). 
 
3.3.3 Statistical analysis 
 
Spearman's rank correlation was performed using GraphPad Prism (version 5.00) to 
evaluate the correlation between the PPD ELISA and DPP VetTB assay for the 20 bTB-
positive buffalo. A t-test was performed to compare the means between the bTB-
positive and bTB-negative cohorts on the PPD ELISA.  
 
3.4 MCP-1 diagnostic performance 
 
3.4.1 MCP-1 ELISA  
 
Anti-bovine MCP-1 capture antibody (catalog no. PB0092B-100; Kingfisher Biotech 
Inc., St Paul, MN, USA) diluted 1:400 in PBS was added to each well (100 µl/well) of 
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a 96-well flat-bottom polystyrene plate (Nunc, New York, USA) and incubated 
overnight at 4°C. Plates were decanted and then washed five times with a wash buffer 
made up of PBS and 0.05% Tween 20 (Sigma-Aldrich, St. Louis, MO, USA). A 
blocking buffer (BB) consisting of 0.1% bovine serum albumin (BSA) (Roche, Basel, 
Switzerland) and 0.05% Tween 20 in 1X PBS was added at a volume of 200 µl to each 
well before being incubated for 1 hour at RT. The plates were washed as above before 
addition, to each well, of 100 µl of plasma, diluted 1:100 in BB. In addition, a dilution 
series of recombinant bovine MCP-1 protein (catalogue no. RP0027B-005; Kingfisher 
Biotech Inc., St Paul, MN, USA) in BB, ranging from 0 to 2500 pg/ml was added to 
separate wells. Samples were incubated for 2 hours at RT. Following another wash step, 
the plates were incubated at RT for 1 hour after addition of 100 µl/well of biotinylated 
anti-bovine MCP-1 detection antibody (catalogue no. PB0091b-050; Kingfisher 
Biotech Inc., St Paul, MN, USA) diluted 1:4000 in BB. The plates were washed as 
above and 100 µl/well of streptavidin-horseradish peroxidase (R&D Systems, USA) 
diluted 1:200 in BB was added to each well and incubated for 30 min at RT. After a 
final wash step, 100 µl/well of TMB was added to each well and incubated for 15 min 
in the dark. The reaction was stopped with 50 µl/well of 2M H2SO4, and the optical 
density (OD) was measured at 450nm using a LT-4000 Microplate Reader (Labtech, 
Vienna, Austria). The MCP-1 concentration in each sample was calculated in GraphPad 
Prism (version 5.00) using the standard curve generated from the serial dilution of 
recombinant bovine MCP-1. The antigen-specific release of MCP-1 was determined by 
subtracting the MCP-1 concentration in the Nil sample from the MCP-1 concentration 
in the corresponding TB-antigen stimulated sample. 
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3.4.2 Protein stability 
 
3.4.2.1  Plasma storage stability 
 
The stability of plasma MCP-1 on Whatman® protein saver cards (PSC) (Sigma-
Aldrich, St. Louis, MO, USA) was assessed in samples from two animals; one with 
a high concentration of MCP-1 (59164.79 pg/ml) and one with a lower 
concentration (5707.53 pg/ml). Plasma was spotted onto PSC in duplicate volumes 
of 1 µl and 5 µl and left to dry for 30 min. The card was then sealed in a plastic 
sleeve and stored in the dark at RT for 11 days. In addition, aliquots of plasma 
samples were stored in microcentrifuge tubes at -80°C for this period.  Hereafter, a 
paper punch was used to cut out a 5 mm circle of card containing the dried plasma 
spot. The concentration of MCP-1 in all samples was measured by ELISA, as 
described above, with the following modification: for plasma stored on PSCs, a 
single punched-out circle was added to a well containing 100 µl of BB.  
 
3.4.2.2 Heat-treatment stability 
 
Plasma from two buffaloes was diluted in BB in individual tubes to a final volume 
of 200 µl at dilutions of 1:5, 1:20 and 1:100. The tubes were then placed in a heat-
rack, preheated to 65°C, and heat-shocked for 20 min. MCP-1 protein levels were 
quantified via ELISA using the heat-shocked plasma as test sample, the 1:100 
dilution was added directly to the wells of the ELISA plate whereas the 1:5 and 1:20 
were diluted appropriately in blocking buffer to 1:100 before being added to the 
wells. A plasma sample that was diluted to 1:100 and stored at 4°C during the 20 
min heat-shock was used as a control to assess the effect of heat on the protein. 
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3.4.3 Statistical analysis 
 
A t-test was performed in GraphPad Prism (version 5.00) to calculate if there was a 
significant difference between the means of bTB-positive and bTB-negative animals 
when evaluating the diagnostic performance of MCP-1. When comparing three or more 
conditions for the peptide stimulation, a Kruskal-Wallis test was performed; if the 
medians were significantly different (p<0.05) a Mann Whitney test was performed 
between individual groups. 
 
3.5 Validation of reference gene stability 
 
3.5.1 Sample selection 
 
The samples used were obtained from a QFT-TB and QFT-Nil tube from 8 bTB-
positive animals in order to assess the variation of gene expression between the two 
treatments. RNAlater®-stabilized whole-blood samples were used for RNA extraction 
as described below.  
 
3.5.2 RNA extraction and reverse transcription 
 
Total RNA was isolated from samples using the RiboPure™-Blood Kit (Ambion, 
California, USA) according to the manufacturer’s protocol. The quantity and quality of 
extracted RNA was estimated using the NanoDrop 1000 spectrophotometer (Thermo 
Fisher Scientific, USA) and samples stored at −80°C. RNA samples with A260/A280 
> 1.8, A260/A230 between 2.0-2.2 and a concentration of >30 ng/ml were chosen for 
cDNA synthesis.  First-strand cDNA was synthesized from 200 ng of RNA from each 
sample using the QuantiTect Reverse Transcription Kit (Qiagen, Netherlands). The 
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cDNA sample was then diluted in RNAse-free H20 to a final volume of 40 µl and stored 
at −80°C. 
 
3.5.3 Sequencing of buffalo reference genes 
 
For selected reference genes (Table 1), the mRNA sequence of the domestic cow (Bos 
Taurus) was obtained from the nucleotide database of the National Center for 
Biotechnology Information (NCBI, http://www.ncbi.nlm.nih.gov) and Ensemble 
genome browser (http://www.ensembl.org/). Regions in the 5' untranslated region (5′ 
UTR) and 3’UTR of these sequences were selected for primer binding, thereby ensuring 
complete coverage of the gene transcript. Using the online software Primer3Plus 
(http://www.bioinformatics.nl/cgi-bin/primer3plus/primer3plus.cgi), primers were 
designed to prime in the 5’UTR and 3’UTR regions. The cDNA from two animals was 
used for PCR as follows. Each PCR reaction consisted of 2.5 µl 10x PCR buffer, 0.125 
µl HotStarTaq DNA polymerase (both Qiagen), 1 µl template cDNA, 0.5 µl (0.2 mM 
each) dNTPs (Promega Corporation, USA), 1 µl (0.4 µM) of each primer (Inqaba 
biotec, Pretoria, RSA) and 18.875 µl of DNAse-free H2O (Applied Biosystems, 
California, USA). An initiation step of 95°C for 15 min was followed by 35 cycles of 
94°C for 1 min, 55°C for 1 min, and 72°C for 1 min. Thereafter, a final extension step 
at 72°C for 10 min. Gel electrophoresis was performed on the resulting PCR products; 
bands of the correct corresponding sizes confirmed that amplification of the transcripts 
was successful. PCR products were sequenced using a 3130xl Genetic Analyzer 
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3.5.4 qPCR assay development 
 
Primers for qPCR were designed using Primer3Plus and the African buffalo gene 
sequences obtained as above. Primer selection criteria included an amplicon size 
between 80 – 150bp, a GC content of 40-60% and an optimal Tm of 60°C. All primers 
were designed either to anneal across exon-exon boundaries, or anneal to exons 
separated by a large intron, thus minimizing genomic DNA amplification.  
qPCRs were performed in 96-well MicroWell™ plates (Sigma-Aldrich, St. Louis, MO, 
USA) using the CFX96 real-time PCR detection system (Biorad, California, United 
States). Reactions were performed in triplicate with each well containing 5 µl iTaq™ 
Universal SYBR® Green supermix (Biorad, California, United States), 1 µl cDNA, 0.5 
µl of each primer (a final concentration of 250nM each) and 3 µl of DNAse-free H20. 
A negative control (all reagents except template cDNA) was included for each assay to 
confirm the absence of any DNA contamination. The cycling conditions consisted of 
an initial denaturation at 95°C for 30 seconds (s), followed by 40 cycles of 5 s 
denaturation at 95°C and 30 s annealing-elongation at 60°C. A melt curve analysis from 
70°C-90°C with increments of 0.5°C was used to ensure a single product was being 
amplified in each reaction.  
 
3.5.5 Optimization  
 
Annealing temperature for each primer set was optimized using a temperature gradient 
with temperatures of 57°C, 60°C and 63°C. PCR efficiency for each primer set was 
calculated using a standard curve made up of serial dilutions of pooled cDNA samples 
from 2 selected animals with the highest mRNA concentrations (118.9 ng/µl and 112.9 
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ng/µl). Beginning at approximately 60 ng/µl, the cDNA sample was serially diluted 4-
fold covering 7 concentration points with 3 replications at each point.  
 
3.5.6 Data analysis 
 
Data from the qPCR reactions was acquired using Bio-Rad CFX Manager software 
(version 3.1) and recorded as Quantification cycle (Cq) values, i.e. the PCR cycle at 
which a fluorescence signal is first detected above an automatically determined 
threshold value. The mean Cq value for each reference gene was calculated from the 3 
replicates of each sample and used for further analyses. The PCR efficiency of each 
primer set was calculated from the Cq values of the standard curve using GraphPad 
Prism software (version 5.00) and the equation E = 10[-1/slope]. Relative gene expression 
data were analysed using the geNorm (Vandesompele et al. 2002) and NormFinder 
(Andersen et al. 2004) Microsoft Excel applets. A NormFinder package which runs in 
the ‘R’ software environment (version 2.10.0) was also used in order to compare results 
between the two methods. Cq values were converted into relative quantities, and the 
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Chapter 4 - Results: 
 
4.1 Animal cohorts 
 
Archived plasma samples (collected between 2011 and 2013) and prospectively 
collected plasma and serum samples (collected in 2015) were utilized in separate sub-
studies as follows: 
1) Cohort 1 - Pilot study: PPD ELISA vs DPP VetTB (3.3) 
Archived plasma samples of 20 bTB-positive buffaloes sampled in 2012. 
2) Cohort 2 - Prospective study: PPD ELISA (3.3) 
Serum samples, collected in 2015, from 30 bTB-positive buffaloes and 32 bTB-
negative buffaloes, sampled pre-TST. 
3) Cohort 3 - Pilot study: MCP-1 (3.4) 
Archived plasma, collected in 2013, derived from mQFT-processed blood from 
17 bTB-positive buffalo and 20 bTB-negative buffalo, sampled pre-TST. 
4) Cohort 4 - Prospective study: MCP-1 (3.4) 
The plasma samples used for this study were from 10 bTB-positive buffalo and 
9 bTB-negative buffalo sampled in 2015 and stimulated in mQFT. Samples 
were collected post-TST. 
5) Cohort – 5 Reference gene selection (3.5) 
Samples from 8 bTB-positive buffalo sampled in 2011 and stimulated in mQFT 
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Figure 1. IgG antibody titres against PPD as measured by ELISA (∆OD) and 
against MPB83 measured using a commercial rapid test (RU) in a cohort of 20 
bTB-positive buffalo. Solid lines represent medians. 
4.2 Serology 
 
Antibody responses in 20 bTB positive African buffalo (QFT and TST positive reactors) were 
evaluated using an in-house PPD ELISA and results compared with the Chembio® DPP VetTB 
assay. Figure 1 shows the antibody response analysed using the PPD ELISA (ΔOD) and 
Chembio® DPP assay (reflectance units, RU). Results displayed for the DPP assay correspond 
to the T1 antigen test line (MPB83) only. Based on the presence of a visible line on either 
antigen band, 9/20 buffalo were seropositive. Values for each assay are displayed in Table 1 in 
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Figure 2. Scatterplot showing significant correlation in IgG antibody titers between 
the Chembio DPP assay (RU) and PPD ELISA (ΔOD) in bTB-positive buffalo (p = 
0.0008, Spearman’s r = 0.6868). 
There was a significant correlation (p = 0.0008) observed between the antibody response 
measured by PPD ELISA and the Chembio® DPP assay as determined by Spearman's rank 
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The antibody response to bovine PPD was evaluated by ELISA for a cohort of bTB negative 
(n = 32) and bTB positive (n = 30) African buffaloes characterized using the Bovigam® and 
TST (Cohort 2). There was no significant difference (p = 0.8380) observed between the means 



























Figure 3. PPD specific antibody response measured by ELISA. Lines represent the mean and 95% 
confidence interval (CI). bTB-negative 95% CI = 0.5913 to 0.9128; bTB-positive 95% CI = 0.5828 
to 0.8773 
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Figure 4. ESAT-6/CFP-10 antigen specific release of MCP-1 calculated as delta-
pg/ml between an antigen stimulated sample and a control (Nil) sample. Mean and 
95% CI shown.  
4.3 MCP-1 diagnostic performance 
 
4.3.1 MCP-1 ELISA 
 
The ESAT-6/CFP-10-specific release of MCP-1 was compared in bTB positive (n = 17) and 
bTB negative buffaloes (n= 20) (Cohort 3). There was a significant difference between the 
means of these groups (p = < 0.0001) (Figure 4). The mean ΔMCP-1 value determined for the 
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Figure 5. ESAT-6/CFP-10 antigen specific release of MCP-1 calculated as delta-pg/ml 
between an antigen stimulated sample and a control (Nil) sample. Lines represent the mean 
and 95% CI. bTB positive 95% CI = 33047 to 62690; bTB negative 95% CI = 8873 to 
37250. 
For bTB-positive (n = 10) and bTB-negative (n = 9) buffaloes (Cohort 4), the antigen-specific 
release of MCP-1 was calculated as the difference in the MCP-1 concentration of the antigen 
(ESAT-6/CFP-10) stimulated sample and the control (Nil) sample (ΔMCP-1). The mean 
ΔMCP-1 concentration for the bTB-positive animals was 47 869 pg/ml and 23 061 pg/ml for 
the bTB-negative animals (Figure 5). The ΔMCP-1 results for these groups was significantly 
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Figure 6. MCP-1 concentration of two bTB-positive buffaloes after storage of plasma 
samples on protein saver cards in aliquots of 1 µl and 5 µl for a period of 11 days. 
4.3.2 Plasma storage stability 
 
The protein stability of MCP-1 after storage for 11 days on protein saver cards and frozen at -
80°C was evaluated by ELISA. For buffalo B10, the MCP-1 concentration was 59 164 pg/ml 
in plasma stored at -80°C; 44 445 pg/ml in the 1 µl aliquot stored on a PSC; and 42 360 pg/ml 
in the 5 µl aliquot stored on a PSC. For buffalo B8, the MCP-1 concentration was 5707 pg/ml 
in plasma stored at -80°C;  819 pg/ml in the 1 µl aliquot stored on a PSC; and 3608 pg/ml in 
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Figure 7. Graph representing the plasma concentration of MCP-1 from two bTB-
positive buffaloes after 20 minutes of heat-treatment at 65°C for various dilutions. 
4.3.3 Heat-treatment stability 
 
The ability of plasma MCP-1 to withstand heat-treatment was assessed. For buffalo B41, the 
MCP-1 concentration in the untreated plasma sample was 52 118 pg/ml. In plasma diluted 1:5, 
1:20 and 1:100 in BB and  heated for 20 min at 65°C, the MCP-1 concentrations were 48 935 
pg/ml, 56 907 pg/ml, and 61 436 pg/ml, respectively (Figure 7). For buffalo B32, the MCP-1 
concentration in the untreated sample was 22 977 pg/ml. In plasma diluted 1:5, 1:20 and 1:100 
in BB and heated for 20 min at 65°C, the MCP-1 concentrations were 24 326 pg/ml,  30 126 
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Figure 8.  Induction of MCP-1 in response to stimulation with a 0.1% DMSO solution compared 
to saline. Furthermore an observed reduction in MCP-1 when stimulated with BSA or KLH 
peptides dissolved in 0.1% DMSO. Lines represent medians. 
4.3.4 MCP-1 induction in response to peptides 
 
Stimulation with irrelevant peptides was investigated in an attempt to decrease the non-specific 
induction of MCP-1 observed previously (Figure 4). There was a large induction of MCP-1 in 
the sample co-incubated with 0.1% DMSO solution compared to the Nil (Saline) sample. When 
the induction of MCP-1 was measured between the 0.1% DMSO solution and the KLH and 
BSA peptide solutions dissolved in 0.1% DMSO, there was a decrease in MCP-1 concentration 
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Figure 9. Co-incubation of blood samples with saline compared to stimulation with 
BSA and KLH peptides dissolved in PBS revealed no significant difference (p = 
0.2112) between the median MCP-1 concentrations.  
A Kruskal-Wallis test showed a significant difference (p = < 0.0001) between the median MCP-
1 concentrations of the conditions.  A Wilcoxon matched pairs test showed a significant 
difference (p < 0.05) between the medians of saline (17 942 pg/ml) compared to 0.1% DMSO 
(74 712 pg/ml), 0.1% DMSO (74 712 pg/ml) compared to BSA(DMSO) (15 470 pg/ml) and 
0.1% DMSO compared to KLH(DMSO) (19 228 pg/ml). There was no significant difference 
observed between the medians of BSA(DMSO) and KLH(DMSO) samples themselves (Figure 
8). 
 
As calculated by a Kruskal-Wallis test, there was no significant difference observed between 
the medians of samples co-incubated with saline (PBS) and samples stimulated with BSA and 
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4.4 Reference gene selection 
 
4.4.1 Reference gene sequencing 
 
Table 2 lists primers used for sequencing of selected reference gene mRNA transcripts of the 
African buffalo.  PCR products were analysed via gel electrophoresis to confirm they were the 
correct length. Transcript sequences, aligned to those of the domestic cow, are presented in 
Appendix II. The mRNA transcripts of the buffalo reference genes shared homology of 
between 98% and 100% with the transcripts of the cow. 
 
 
Table 2. Primers used for the sequencing of selected African buffalo reference genes, indicating gene 








F:  TAACTTCTGTGCTGTGCCAG 





F:  TCGACACCGCAACCAGTTCG 





F:  CCACCGCGCAGCTGCTGCAA 





F:  TCCGGACACAGAACATCCAGT 





F:  CCTTGCAGACGCCGCCACCT 





F:  AAGTAAGGAGGTCTCTATACC 





F:  TTGCCAAGAAGGTGAACGTC 





F:  CTCCCCAGACTGCCTTCAG 
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4.4.2 qPCR development 
 
The primers used for qPCR and subsequent gene expressions stability analysis are listed in 
Table 3. The qPCR amplicon sizes for each gene were confirmed by gel electrophoresis, 
furthermore the amplicon of each primer set produced a characteristic melt curve (data not 
shown). Annealing temperature for all primer sets of 60°C was chosen for the analysis. The 
efficiency of all qPCRs ranged from 100% – 119%, and all r2 values were >0.980 (Table 3). 
 
 
Table 3. Reference genes included in the gene expression stability analysis, indicating gene name, 
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Figure 10. The average expression stability values (M) of each reference gene as calculated using the 
geNorm Excel applet. The lower the M value, the more stable the gene is under the tested conditions. 
In this case the most stable genes would be H3F3A and PPIA. 
4.4.3 Reference gene expression stability analysis 
 
The average stability values for each reference gene were calculated to determine the stability 
in expression of genes in the antigen-stimulated and unstimulated samples. The expression 
stability of the 8 reference genes as determined by geNorm are shown in Figure 10 with a lower 
M value representing a more stable gene. The expression stability of the tested genes were 
observed to be different, with the M values ranging from 0.22 to 0.47. The average M value of 
the pair H3F3A and PPIA was lowest at 0.22 and this pair was identified as the most suitable 
reference genes. The M value of GAPDH was the highest at 0.47 and therefore represented the 
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The NormFinder algorithm was also used to calculate the expression stability of the 8 reference 
genes. Higher expression stability is indicated by a lower stability value, referred to as the 
NormFinder stability index. Figure 11 shows the expression stability of each gene as calculated 





















Figure 11. NormFinder gene expression stability results. a) Gene expression 
stability calculated using a NormFinder Excel applet. b) Gene expression 
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The stability values calculated using the NormFinder Excel applet ranged from 0.008 to 0.035, 
the two best performing reference genes were PPIA (0.008) and H3F3A (0.010). The two most 
unstable genes according to the Excel applet were GAPDH (0.035) and B2M (0.030) (Figure 
11a). The NormFinder ‘R’ algorithm was in agreement with the Excel applet in selecting the 
most stable reference gene as PPIA with a stability value of 0.11, closely followed by the two 
next most stable genes ACTB and YWHAZ which had a stability value of 0.14. The two worst 
performing reference genes according to the ‘R’ algorithm were GAPDH (0.35) and B2M 
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Chapter 5 - Discussion: 
 
Our results show that the use of bovine PPD as a capture antigen in an indirect ELISA is capable 
of detecting M. bovis-specific antibodies in bTB-positive buffalo. This was confirmed by using 
a commercial rapid test capable of detecting antibodies against the antigens MPB83 and ESAT-
6/CFP-10 of M. bovis. To our knowledge, this is the first study conducted in South Africa to 
evaluate the use of a PPD ELISA for the detection of humoral responses in bTB-positive 
African buffalo. In an initial study, the animals tested revealed a broad range of PPD-specific 
antibody titres. There were a few high (n = 3/20) and intermediate (n = 4/20) reactors to PPD 
while the majority of animals showed a negligible PPD-specific antibody response. The DPP 
VetTB assay was chosen because of its reported ability to detect antibodies against M. bovis in 
other species, and to evaluate its use in buffalo compared to the in-house PPD ELISA 
(Greenwald et al. 2009, Lyashchenko et al. 2013). For the DPP VetTB, a similar pattern of 
antibody responses was observed, with 9/20 (45%) of the bTB-positive buffalo identified as 
being sero-positive to the MPB83 antigen. In contrast, few animals (2/20) were sero-reactive 
to ESAT-6/CFP-10, a finding similar to Green et al. (2009) we showed that antibody reactivity 
to MPB83 is a more consistent indicator of M. bovis infection than reactivity to ESAT-6/CFP-
10. Further analysis showed that there was a significant correlation between the results of the 
PPD ELISA and the DPP VetTB, thus indicating that both assays are able to detect humoral 
responses to M. bovis infection in African buffalo. MPB83 expression is known to be high in 
M. bovis, therefore the correlation between the PPD ELISA and the DPP VetTB may be due to 
antibodies binding MPB83 in the PPD (McNair et al. 2001). 
In order to further characterize the antibody response to infection, the in-house ELISA was 
evaluated in a larger cohort of animals (Cohort 2). PPD-specific-Antibodies were detected in 
both positive and negative buffalo with a widely overlapping range of titres with no significant 
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difference in titre between the groups (Figure 3). A similar overlap of antibody responses was 
observed by other researchers using a PPD ELISA to measure antibody levels in a cohort of 
283 cattle from bTB-infected herds and 277 cattle from a bTB-free area (Amadori et al. 1997). 
Our results demonstrate that the use of this PPD ELISA for detection of M. bovis-specific 
antibodies may not be a sufficiently specific tool for the diagnosis of bTB in African buffalo. 
The overlapping antibody response seen between the bTB-positive and negative groups may 
be due to shared antigens between M. bovis and related bacterial species which can include 
other mycobacteria (such as environmental non-tuberculous mycobacteria), including M. 
avium, or gram-positive bacteria A potential control for this could be the inclusion of an M. 
avium PPD-coated well in the assay, allowing for measurement of the differential antibody 
response to M. bovis and M. avium.  The bTB-negative buffalo in the present study were all 
from an area endemic for bTB, it is possible they have been exposed to M. bovis and could be 
at an early stage of infection, however they may have also become anergic and therefore lack 
a CMI response. In agreement with our findings, other studies evaluating the performance of a 
PPD ELISA for the detection of antibodies against M. bovis in cattle have shown varying 
sensitivity and specificity. Ritacco et al. (1986) recorded a sensitivity of 90% in M. bovis 
culture-positive cattle and a specificity of 89.8% in a herd of healthy cattle from a bTB-free 
area. However, when the study was later repeated using new cohorts the sensitivity dropped to 
73% while the specificity was higher at 94% (Ritacco et al. 1990). Another study which showed 
promising results was conducted by Lilenbaum et al. (1999) who determined the sensitivity 
and specificity of a PPD ELISA in cattle to be 86.7% and 90.6%, respectively. In contrast, 
there have been reports of low sensitivity, 63% and 48%, as well as low specificity, 52% and 
55%, for the detection of antibodies in cattle using a PPD ELISA (Auer et al. 1987, Sayin et 
al. 2013). It is therefore evident that test performance of the PPD ELISA in cattle can vary, this 
may depend on the location where the samples were collected, since it has been shown that 
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prevalence and stage of disease affects diagnostic sensitivity and specificity (Bentley et al. 
2012). 
Although serological tests have limitations for the diagnosis of bTB, they have several 
advantages over the TST; animals are only handled once for the collection of blood samples, 
and sampling can be repeated without affecting the immune sensitization of the animal. 
Antibodies tend to appear in more advanced stages of disease when there is a high antigenic 
load and have been shown to correlate with disease pathology. Therefore serological tests can 
be useful in identifying animals that are anergic, and which fail to respond to CMI based 
diagnostics such as the TST (Neill et al. 2001, Plackett et al. 1989).  
Two highly immunogenic proteins of M. bovis, MPB70 and MPB83 have been used as coating 
antigens in ELISAs in an attempt to increase the detection of antibodies against M. bovis in 
infected animals. Wood et al. (1992) developed an ELISA using MPB70 and reported a 
sensitivity and specificity of 18.1% and 96.4%, respectively, in cattle infected with M. bovis 
and another group from a TB-free area. In another study which used MPB83 as a capture 
antigen, sensitivity was estimated at 37.5% while specificity was 89%. Although the 
sensitivities for assays using these proteins were very low, the high specificities indicate 
potential for their use in serological assays for screening large herds for M. bovis (McNair et 
al. 2001). Other serological assays making use of the immunogenicity and specificity of these 
proteins include the commercially available IDEXX M. bovis Ab test which uses an ELISA for 
the detection of antibodies against both MPB70 and MPB83 (Waters et al. 2011). This test, in 
combination with conventional CMI tests, may increase detection of infected animals that may 
be missed by the TST alone. Validation of the IDEXX in a cohort of naturally infected cattle 
reported an apparent test sensitivity of 63% and specificity of 98%; however sensitivity was 
shown to increase with disease severity (Waters et al. 2011).  
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MCP-1 is essential for B-cell proliferation and antibody class switching, in addition it is 
involved in the formation of granulomas by recruiting immune cells to sites of infection 
(Deshmane et al. 2009). Therefore, we evaluated the use of MCP-1 as a diagnostic marker for 
M. bovis infection and found a significant difference in the mean MCP-1 concentration between 
bTB-positive and bTB-negative buffaloes (Cohort 3). However, the TB-antigen stimulated 
samples from bTB negative animals had lower plasma concentrations of MCP-1 compared to 
the Nil (saline) sample, which caused the differential concentration to be a negative value 
(Figure 4). The mechanisms resulting in this phenomenon are unclear, but incubation and 
handling of blood samples may cause spontaneous induction of MCP-1 by monocytes. Antigen 
processing by monocytes may alter the MCP-1 induction pathways, leading to less MCP-1 
released in an antigen stimulated sampled compared to the Nil. This only occurs in bTB-
negative animals that do not elicit a memory immune response to the antigens. In this study it 
was shown that MCP-1 concentrations in samples co-incubated with saline at 37°C for 24, 48 
and 72 hours had a steady increase in MCP-1 concentration over time (data not shown), 
supporting the idea that MCP-1 is non-specifically released during incubation. To control for 
the non-specific response, we determined the effect on MCP-1 induction by co-incubating the 
blood with peptides that would not induce a memory immune response. DMSO was used as a 
solvent for the peptides because the rate of dissolution of peptides into these solvents is usually 
higher than in a water/solvent mixture (Narita et al. 1988). Therefore as a control we included 
0.1% DMSO on its own as a co-incubation condition to evaluate its effect on MCP-1 induction.  
There was a significant increase in the concentration of MCP-1 in the sample co-incubated 
with 0.1% DMSO compared to the Nil (Saline) sample. This is in contrast to a study which 
showed that 1% DMSO decreased the induction of MCP-1 mRNA in a whole-blood stimulation 
assay (Xing et al. 2007b). However, a study by the same group determined that H2O2 in whole-
blood induced significant increases in MCP-1, while MCP-1 production decreased at H2O2 
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concentrations higher than 1.0 mmol/L, suggesting a cytotoxic effect (Xing et al. 2007a). 
Knowing that MCP-1 induction due to H2O2 was concentration dependent, it is possible that 
lower concentrations of DMSO could induce MCP-1 while higher concentrations as seen by 
Xing et al. 2007b could have an inhibitory effect. However, this is still unknown and further 
research is required to understand the mechanisms of MCP-1 induction due to DMSO. 
Interestingly, in the samples stimulated with KLH and BSA peptides dissolved in 0.1% DMSO, 
there was a significant decrease in MCP-1 concentration compared to the 0.1% DMSO alone 
(Figure 8). This seems to suggest that in the presence of a peptide, MCP-1 induction is skewed 
or inhibited. There was no significant difference observed in MCP-1 levels between samples 
co-incubated with saline and samples stimulated with KLH and BSA peptides dissolved in 
saline (Figure 9). However, the range of MCP-1 concentrations is noticeably decreased when 
comparing the saline co-incubated samples to that of either peptide dissolved in saline, thus 
suggesting that the presence of the peptides affected the induction of MCP-1, albeit to a lesser 
effect then observed with DMSO. 
A second cohort of bTB-positive and bTB-negative buffaloes (Cohort 4) also showed a 
significant difference in antigen-specific MCP-1 release between these groups (Figure 5). 
However, the slight overlap of MCP-1 concentrations between the groups suggests that it has 
a lower sensitivity than the detection of IFN-γ. In contrast to our previous observations, there 
was no reduction in MCP-1 concentration in the antigen-stimulated samples from bTB negative 
animals compared to saline samples. The mechanisms affecting MCP-1 induction are unclear, 
however, our results from a pilot study (data not shown) showing an increased non-specific 
induction of MCP-1 over time suggest that the length of time from when blood is first drawn 
to when the samples are processed could affect the results. The results from our initial 
observation on the diagnostic performance of MCP-1 were collected from buffalo before the 
TST was performed (Cohort 3), whereas the samples from our second observation were 
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collected from animals 3 days after the TST (Cohort 4), it is possible this could have an 
influence on the induction of MCP-1 due to immune sensitization. 
The storage of stimulated plasma on protein saver cards (PSC) can facilitate the transport of 
plasma samples containing proteins of diagnostic importance (Duncombe et al. 2013). The PSC 
are small and light-weight and can be transported at ambient temperature without the need for 
cooling equipment. Results of MCP-1 storage stability experiments confirmed that the protein 
was still detected in equivalent amounts after 11 days of storage on protein saver cards (PSC) 
(Figure 6). Plasma from two animals were used, one with a high MCP-1 concentration and one 
with a low concentration to show that the initial concentration of plasma MCP-1 did not affect 
the stability of the protein. There was also no noticeable difference between the MCP-1 
concentration of the 1 µl and 5 µl aliquots, although 5 µl is recommended because there is less 
chance for error. In a study investigating the stability of IFN-γ on PSC there was a progressive 
loss of IFN-γ signal over 10 days when stored at room temperature (Duncombe et al. 2013) 
The heat stability of MCP-1 was assessed by heat-treatment of plasma at 65°C, a temperature 
used to inactivate harmful pathogens in samples. Results showed that MCP-1 can withstand a 
heat-treatment of 65°C for up to 20 minutes without any loss in signal. This property of MCP-
1 could prove useful for applications which require inactivation of potential pathogens in 
plasma such as Brucella organisms (Weinhold et al. 2013) or Foot-and-Mouth Disease Virus 
(Kamolsiripichaiporn et al. 2007), while still maintaining the diagnostic use of the sample for 
cytokine determination. The heat-treated plasma could then be blotted onto a PSC and 
transported via post or courier in a safe and efficient manner. We observed that MCP-1 
concentrations were higher in the heat-treated plasma samples compared to the control sample 
which was stored at 4°C. Plasma was diluted 1:5, 1:20 and 1:100 in PBS before heat treatment 
to increase volume to prevent the plasma coagulation. The control sample was diluted 1:100 in 
PBS and stored at 4°C during the heat shock step; this allowed the sample to be directly 
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transferred to the ELISA for MCP-1 quantification. Our results show that samples at the highest 
dilution have greater levels of MCP-1 after heat treatment compared to lower dilutions and the 
control (Figure 7).  A possible explanation to describe these observations could include a 
conformational change in the protein during heat-shock that allows extra epitopes of MCP-1 to 
be exposed and therefore the binding of more antibodies to increase the signal (Zhang et al. 
1999). Alternatively, heat-inactivation of an inhibitory molecule, such as an enzyme that breaks 
down MCP-1, might increase detection of this molecule as enzymes are adversely affected by 
high temperature (Bennett et al. 1969). For example, Trypsin is an enzyme involved in the 
breakdown of many different proteins. Studies have shown that Trypsin inhibitors can be 
inactivated after heat treatment at 70°C, thus it is possible that enzymes which break down 
MCP-1 are inactivated by the heat treatment (Kozlowska et al. 1980). 
In addition to evaluating antibody and cytokine production as a measure of humoral responses 
to M. bovis infection in buffalo, investigation of changes in gene expression could better 
characterize the complex immune response occurring in the host. For this purpose, we 
investigated the expression stability of selected reference genes in antigen-stimulated blood 
from bTB-positive buffaloes.  To our knowledge this is the first study of the stability of selected 
reference genes in antigen stimulated whole-blood samples from bTB-positive African buffalo. 
The two software programs used for the stability analyses showed similar results, with PPIA 
and H3F3A showing greatest stability (Figure 10 and 11).  In contrast, GAPDH and B2M 
showed much lower expression stability suggesting that they are unsuitable for use as reference 
genes in African buffalo under the experimental conditions described.  
Additionally, we sequenced the eight reference genes of the African buffalo using primers 
designed from the corresponding genes in the domestic cow to assess homology between 
species. All the sequenced genes shared high homology with their cow counterparts, ranging 
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from 98-100% (Appendix II). This could prove useful in designing qPCR primers for cows or 
buffalo for a non-species specific GEA. 
Studies investigating the gene expression profile in response to bTB infection have been 
conducted in cattle using various cell and tissue types. The reference genes chosen for each 
study differed based on type of sample used. Two separate studies investigating the gene 
expression profiles of M. bovis antigen stimulated PBMC from infected cattle used ACTB and 
GAPDH as reference genes, respectively (Thacker et al. 2007, Blanco et al. 2011). GAPDH 
was used as a reference gene in qPCR GEA investigating the expression of genes in lymph 
nodes of M. bovis infected cattle (Widdison et al. 2006, Witchell et al. 2010), while another 
study investigating the expression of genes in the lungs of M. bovis infected cattle used the 
reference gene U1 small nuclear ribonucleoprotein (U1) (Shu et al. 2014). ACTB was used as 
a reference gene in the only other study of gene expression in African buffalo using M. bovis 
antigen stimulation of whole blood (Parsons et al. 2011). Vorachek et al. (2013) validated the 
stability of reference genes in bovine neutrophils in animals with and without selenium 
supplementation and discovered that the commonly used genes ACTB and HPRT1 were 
unreliable, whereas YWHAZ and phosphoglycerate kinase (PGK1) ranked among the top most 
stable genes under their experimental conditions. Therefore genes commonly chosen as 
reference genes may not behave as expected depending on cell type and treatment conditions, 
hence why it is important to evaluate the expression stability of candidate reference genes for 
the specific experimental conditions. The role of a GEA for the diagnosis of bTB in Africa 
buffalo has been investigated with promising results, however, further research and 
optimization is required to develop more sensitive diagnostic tests for bTB (Parsons et al. 
2011). 
There were certain limitations to this study. Firstly, we did not include an avian PPD antigen 
coated well in the PPD ELISA; this would have allowed us to control for cross-reactivity 
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between antibodies against M. bovis and those against M. avium. Secondly, further 
experimentation is needed to determine the causing of the variations in MCP-1 concentrations 
of animals sampled on different occasions.  This is most likely caused by a spontaneous MCP-
1 release, which, if controlled for could improve the diagnostic performance of MCP-1. 
Thirdly, due to a lack of post-mortem pathological data, the stage of infection in the bTB-
positive buffaloes was unknown. Without information on the stage of infection, correlations 
cannot be made between characteristics of the immune response and disease pathology.  
 
Chapter 6 - Conclusion: 
The in-house PPD ELISA was able to detect antibodies against M. bovis in bTB-positive 
buffalo. Although the diagnostic sensitivity of this assay was low, the results correlate with a 
commercial rapid test used to detect antibodies against MPB83. The high immunogenicity of 
MPB83, and its increased expression by M .bovis could suggest that the antibodies detected by 
the PPD ELISA are, in part, those against MPB83. Although MCP-1 shows promise as a 
diagnostic biomarker for bTB, it too has a poor sensitivity. Nonetheless, the stability properties 
of MCP-1 during storage and heat treatment, are characteristics which could prove particularly 
useful, especially for the detection of wildlife species co-infected with controlled diseases. 
However, further studies on this cytokine are needed to determine its true role as a diagnostic 
marker of bTB. The reference genes evaluated in this study can be used for the development 
of a diagnostic GEA with greater sensitivity, or to assess a gene expression profile of immune 
genes in bTB-positive buffalo. The use of diagnostic assays measuring both CMI and humoral 
immune response could provide useful information regarding the M. bovis infection status of 
the animal. Although serological tests have been shown to have low sensitivity, they may still 
be used as an adjunct test to help better characterize the immune response to M. bovis infection. 
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Table 1. Antibody titers as measured by the Chembio DPP VetTB assay represented as reflectance units 
(RU). Presence of a visible line on either band was used to define an animal as antibody-positive 
(highlighted in red). Antibody responses to PPD as determined via ELISA are represented as delta-OD 
between antigen and control wells. 








B2 0.0 0.0 0.005 N 
B8 4.3 0.0 0.067 Y 
B10 2.8 0.0 -0.010 N 
B17 2.6 0.0 0.453 N 
B23 7.2 0.0 0.410 Y 
B24 3.4 0.0 0.138 Y 
B25 14.3 0.0 0.439 Y 
B26 0.0 0.0 0.036 N 
B34 9.9 0.0 0.051 Y 
B40 39.0 9.3 1.752 Y 
B41 2.8 0.0 0.078 N 
B44 2.7 0.0 -0.097 N 
B48 0.0 0.0 0.008 N 
B49 3.2 0.0 1.168 Y 
B59 3.0 0.0 0.075 N 
B61 10.9 82.3 1.562 Y 
B63 0.0 0.0 0.043 N 
B65 2.8 0.0 0.059 N 
B67 3.0 0.0 0.078 N 
B69 8.3 0.0 0.370 Y 





Sequences of selected reference genes of the African Buffalo  
 
Note: Start and stop codons are underlined and annealing sites of the qPCR primers are 
highlighted in grey. 
 
GAPDH: 99.20% nucleotide homology between cattle and buffalo sequences. 
 
cow          ATGGTGAAGGTCGGAGTGAACGGATTCGGCCGCATCGGGCGCCTGGTCACCAGGGCTGCT 
buffalo      ATGGTGAAGGTCGGAGTGAACGGATTCGGCCGCATTGGGCGCCTGGTCACCAGGGCTGCT 
             *********************************** ************************ 
 
cow          TTTAATTCTGGCAAAGTGGACATCGTCGCCATCAATGACCCCTTCATTGACCTTCACTAC 
buffalo      TTTAATTCTGGCAAAGTGGACATCGTCGCCATCAATGACCCCTTCATTGACCTTCACTAC 
             ************************************************************ 
 
cow          ATGGTCTACATGTTCCAGTATGATTCCACCCACGGCAAGTTCAACGGCACAGTCAAGGCA 
buffalo      ATGGTCTACATGTTCCAGTATGATTCCACCCACGGCAAGTTCCACGGCACAGTCAAGGCA 
             ****************************************** ***************** 
 
cow          GAGAACGGGAAGCTCGTCATCAATGGAAAGGCCATCACCATCTTCCAGGAGCGAGATCCT 
buffalo      GAGAACGGGAAGCTCGTCATCAATGGAAAGGCCATCACCATCTTCCAGGAGCGAGATCCT 
             ************************************************************ 
 
cow          GCCAACATCAAGTGGGGTGATGCTGGTGCTGAGTATGTGGTGGAGTCCACTGGGGTCTTC 
buffalo      GCCAACATCAAGTGGGGTGATGCTGGTGCTGAGTATGTGGTGGAGTCCACTGGGGTCTTC 
             ************************************************************ 
 
cow          ACTACCATGGAGAAGGCTGGGGCTCACTTGAAGGGTGGCGCCAAGAGGGTCATCATCTCT 
buffalo      ACTACCATGGAGAAGGCTGGGGCTCACTTGAAGGGTGGCGCCAAGAGGGTCATCATCTCG 
             ***********************************************************  
 
cow          GCACCTTCTGCCGATGCCCCCATGTTTGTGATGGGCGTGAACCACGAGAAGTATAACAAC 
buffalo      GCGCCTTCTGCCGATGCCCCCATGTTTGTGATGGGTGTGAACCACGAGAAGTATAACAAC 
             ** ******************************** ************************ 
 
cow          ACCCTCAAGATTGTCAGCAATGCCTCCTGCACCACCAACTGCTTGGCCCCCCTGGCCAAG 
buffalo      ACCCTCAAGATTGTCAGCAATGCCTCCTGCACCACCAACTGCTTGGCCCCCCTGGCCAAG 
             ************************************************************ 
 
cow          GTCATCCATGACCACTTTGGCATCGTGGAGGGACTTATGACCACTGTCCACGCCATCACT 
buffalo      GTCATCCATGACCACTTTGGCATCGTGGAGGGACTTATGACCACCGTCCACGCCATCACT 
             ******************************************** *************** 
 
cow          GCCACCCAGAAGACTGTGGATGGCCCCTCCGGGAAGCTGTGGCGTGACGGCCGAGGGGCT 
buffalo      GCCACCCAGAAGACTGTGGATGGCCCCTCCGGGAAGCTGTGGCGTGACGGCCGAGGGGCT 
             ************************************************************ 
 
cow          GCCCAGAATATCATCCCTGCTTCTACTGGCGCTGCCAAGGCCGTGGGCAAGGTCATCCCT 
buffalo      GCCCAGAATATCATCCCTGCTTCTACTGGCGCTGCCAAGGCCGTGGGCAAAGTCATCCCT 
             ************************************************** ********* 
 
cow          GAGCTCAACGGGAAGCTCACTGGCATGGCCTTCCGCGTCCCCACTCCCAACGTGTCTGTT 
buffalo      GAGCTCAACGGGAAGCTCACTGGCATGGCCTTCCGCGTCCCCACTCCCAACGTGTCTGTT 
             ************************************************************ 
Stellenbosch University  https://scholar.sun.ac.za
81 
 
cow          GTGGATCTGACCTGCCGCCTGGAGAAACCTGCCAAGTATGATGAGATCAAGAAGGTGGTG 
buffalo      GTGGATCTGACCTGCCGCCTGGAGAAACCTGCCAAGTATGATGAGATCAAGAAGGTGGTG 
             ************************************************************ 
 
cow          AAGCAGGCGTCAGAGGGCCCTCTCAAGGGCATTCTAGGCTACACTGAGGACCAGGTTGTC 
buffalo      AAGCAGGCGTCAGAGGGCCCTCTCAAGGGCATTCTAGGCTACACTGAGGACCAGGTTGTC 
             ************************************************************ 
 
cow          TCCTGCGACTTCAACAGCGACACTCACTCTTCTACCTTCGATGCTGGGGCTGGCATTGCC 
buffalo      TCCTGCGACTTCAACAGCGACACTCACTCTTCTACCTTCGATGCTGGGGCTGGCATTGCC 
             ************************************************************ 
 
cow          CTCAACGACCACTTTGTCAAGCTCATTTCCTGGTACGACAATGAATTTGGCTACAGCAAC 
buffalo      CTCAACGACCACTTTGTCAAGCTCATTTCCTGGTACGACAATGAATTCGGCTACAGCAAC 
             *********************************************** ************ 
 
cow          AGGGTGGTGGACCTCATGGTCCACATGGCCTCCAAGGAGTAA 
buffalo      AGGGTGGTGGACCTCATGGTCCACATGGCCTCCAAGGAGTAA 
             ****************************************** 
 
ACTB: 99.08% nucleotide homology between cattle and buffalo sequences. 
 
 
cow          ATGTGCAAGGCCGGCTTCGCGGGCGACGATGCTCCCCGGGCCGTCTTCCCGTCCATCGTG 
buffalo      ATGTGCAAGGCCGGCTTCGCGGGCGACGATGCTCCCCGGGCTGTCTTCCCCTCCATCGTG 
             ***************************************** ******** ********* 
 
cow          GGGCGCCCCCGGCACCAGGGCGTAATGGTGGGCATGGGCCAGAAGGACTCGTACGTGGGG 
buffalo      GGGCGCCCCCGGCACCAGGGCGTAATGGTGGGCATGGGCCAGAAGGACTCGTACGTGGGG 
             ************************************************************ 
 
cow          GATGAGGCTCAGAGCAAGAGAGGCATCCTGACCCTCAAGTACCCCATTGAGCACGGCATC 
buffalo      GATGAGGCTCAGAGCAAGAGAGGCATCCTGACCCTCAAGTACCCCATTGAGCACGGCATC 
             ************************************************************ 
 
cow          GTCACCAACTGGGACGACATGGAGAAGATCTGGCACCACACCTTCTACAACGAGCTCCGT 
buffalo      GTCACCAACTGGGACGACATGGAGAAGATCTGGCACCACACCTTCTACAACGAGCTCCGT 
             ************************************************************ 
 
cow          GTGGCCCCTGAGGAGCACCCCGTGCTGCTGACCGAGGCCCCCCTGAACCCCAAGGCCAAC 
buffalo      GTGGCCCCTGAGGAGCACCCCGTGCTGCTGACCGAGGCCCCCCTGAACCCCAAGGCCAAC 
             ************************************************************ 
 
cow          CGTGAGAAGATGACCCAGATCATGTTCGAGACCTTCAACACCCCTGCCATGTACGTGGCC 
buffalo      CGTGAAAAGATGACCCAGATCATGTTCGAGACCTTCAACACCCCTGCCATGTACGTGGCC 
             ***** ****************************************************** 
 
cow          ATCCAGGCTGTGCTGTCCCTGTATGCCTCTGGCCGCACCACCGGCATCGTGATGGACTCC 
buffalo      ATCCAGGCCGTGCTGTCCCTGTATGCCTCTGGCCGCACCACTGGCATCGTGATGGACTCC 
             ******** ******************************** ****************** 
 
cow          GGTGACGGGGTCACCCACACGGTGCCCATCTATGAGGGGTACGCCCTTCCCCATGCCATC 
buffalo      GGTGACGGGGTCACCCACACGGTGCCCATCTACGAGGGGTACGCCCTTCCCCATGCCATC 
             ******************************** *************************** 
 
cow          CTGCGTCTGGACCTGGCTGGCCGGGACCTGACGGACTACCTCATGAAGATCCTCACGGAG 
buffalo      CTGCGTCTGGACCTGGCTGGCCGGGACCTGACGGACTACCTCATGAAGATCCTCACGGAG 
             ************************************************************ 
 
cow          CGTGGCTACAGCTTCACCACCACGGCCGAGCGGGAAATCGTCCGTGACATCAAGGAGAAG 
buffalo      CGTGGCTACAGCTTCACCACCACGGCCGAGCGGGAAATCGTCCGTGACATCAAGGAGAAG 
             ************************************************************ 
 
cow          CTCTGCTACGTGGCCCTGGACTTCGAGCAGGAGATGGCCACCGCGGCCTCCAGCTCCTCC 
buffalo      CTCTGCTACGTGGCCCTGGACTTCGAGCAGGAGATGGCCACCGCGGCCTCCAGCTCCTCC 
             ************************************************************ 




cow          CTGGAGAAGAGCTACGAGCTTCCTGACGGGCAGGTCATCACCATCGGCAATGAGCGGTTC 
buffalo      CTGGAGAAGAGCTACGAGCTTCCTGACGGGCAGGTCATCACCATCGGCAATGAGCGGTTC 
             ************************************************************ 
 
cow          CGCTGCCCTGAGGCTCTCTTCCAGCCTTCCTTCCTGGGCATGGAATCCTGCGGCATTCAC 
buffalo      CGCTGCCCTGAGGCTCTCTTCCAGCCTTCCTTCCTGGGCATGGAATCCTGCGGTATTCAC 
             ***************************************************** ****** 
 
cow          GAAACTACCTTCAATTCCATCATGAAGTGTGACGTCGACATCCGCAAGGACCTCTACGCC 
buffalo      GAAACTACCTTCAATTCCATCATGAAGTGTGATGTCGACATCCGCAAGGACCTCTACGCC 
             ******************************** *************************** 
 
cow          AACACGGTGCTGTCCGGCGGGACCACCATGTACCCCGGCATCGCGGACAGGATGCAGAAA 
buffalo      AACACGGTGCTGTCCGGCGGGACCACCATGTACCCCGGCATCGCAGACAGGATGCAGAAA 
             ******************************************** *************** 
 
cow          GAGATCACTGCCCTGGCACCCAGCACAATGAAGATCAAGATCATCGCGCCCCCTGAGCGC 
buffalo      GAGATCACTGCCCTGGCACCCAGCACAATGAAGATCAAGATCATCGCGCCCCCTGAGCGC 
             ************************************************************ 
 
cow          AAGTACTCCGTGTGGATTGGCGGCTCCATCCTGGCCTCGCTGTCCACCTTCCAGCAGATG 
buffalo      AAGTACTCCGTGTGGATTGGCGGCTCCATCCTGGCCTCGCTGTCCACCTTCCAGCAGATG 
             ************************************************************ 
 
cow          TGGATCAGCAAGCAGGAGTACGATGAGTCCGGCCCCTCCATCGTCCACCGCAAATGCTTC 
buffalo      TGGATCAGCAAGCAGGAGTACGACGAGTCCGGCCCCTCCATCGTCCACCGCAAATGCTTC 
             *********************** ************************************ 
 
cow          TAG 
buffalo      TAG 
             *** 
 
 
B2M: 98.6% nucleotide homology between cattle and buffalo sequences. 
 
 
cow          ATGGCTCGCTTCGTGGCCTTGGTCCTTCTCGGGCTGCTGTCGCTGTCTGGACTGGACGCC 
buffalo      ATGGCTCGCTTCGTGGCCTTGGTCCTTCTCGGGCTGCTGTCGCTGACTGGACTGGACGCC 
             ********************************************* ************** 
 
cow          ATCCAGCGTCCTCCAAAGATTCAAGTGTACTCAAGACACCCACCAGAAGATGGAAAGCCA 
buffalo      ATCCAGCGTGTTCCAAAGATTCAAGTGTACTCAAGACACCCACCAGAAGATGGAAAGCCA 
             *********  ************************************************* 
 
cow          AATTACCTGAACTGCTATGTGTATGGGTTCCATCCACCCCAGATTGAAATTGATTTGCTG 
buffalo      AATTACCTGAACTGCTATGTGTCTGGGTTCCATCCACCCCAGATTGAAATCGATTTGCTG 
             ********************** *************************** ********* 
 
cow          AAGAATGGGGAGAAGATTAAATCGGAGCAGTCAGACCTGTCTTTCAGCAAGGACTGGTCT 
buffalo      AAGAATGGGGAGAAGATTAAATCGGAGCAGTCAGACCTGTCTTTCAGCAAGGACTGGTCT 
             ************************************************************ 
 
cow          TTCTACCTGCTGTCCCACGCTGAGTTCACTCCCAACAGCAAGGATCAGTACAGCTGCCGA 
buffalo      TTCTACCTGCTGTCCCACGCTGAGTTCACTCCCAACAGCAAGGATCAGTACAGCTGCCGA 
             ************************************************************ 
 
cow          GTGAAACACGTTACTTTGGAACAACCCCGGATAGTTAAGTGGGATCGAGACCTGTAA 
buffalo      GTGAAACACGTTACTTTGGAACAACCCCGGATAGTTAAGTGGGATCGAGACCTGTAA 
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YWHAZ: 99.73% nucleotide homology between cattle and buffalo sequences. 
 
cow          ATGGATAAAAACGAGCTGGTACAGAAGGCCAAACTGGCCGAGCAGGCTGAGCGATATGAT 
buffalo      ATGGATAAAAACGAGCTGGTACAGAAGGCCAAACTGGCCGAGCAGGCTGAGCGATATGAT 
             ************************************************************ 
 
cow          GACATGGCAGCCTGCATGAAGTCTGTAACTGAGCAAGGAGCTGAATTATCCAATGAGGAG 
buffalo      GACATGGCAGCCTGCATGAAGTCTGTAACTGAGCAAGGAGCTGAATTATCCAATGAGGAG 
             ************************************************************ 
 
cow          AGGAATCTTCTCTCAGTTGCTTATAAAAATGTTGTAGGAGCCCGTAGGTCATCTTGGAGG 
buffalo      AGGAATCTTCTCTCAGTTGCTTATAAAAATGTTGTAGGAGCCCGTAGGTCATCTTGGAGG 
             ************************************************************ 
 
cow          GTCGTCTCCAGTATTGAGCAAAAGACGGAAGGTGCTGAGAAAAAACAGCAGATGGCTCGA 
buffalo      GTCGTCTCCAGTATTGAGCAAAAGACGGAAGGTGCTGAGAAAAAACAGCAGATGGCTCGA 
             ************************************************************ 
 
cow          GAATACAGAGAGAAAATAGAGACCGAGCTAAGAGATATCTGCAATGATGTACTGTCTCTT 
buffalo      GAATACAGAGAGAAAATAGAGACCGAGCTAAGAGATATCTGCAATGATGTACTGTCTCTT 
             ************************************************************ 
 
cow          TTGGAAAAGTTCTTGATCCCCAACGCTTCACAAGCAGAGAGCAAAGTCTTCTATTTGAAA 
buffalo      TTGGAAAAGTTCTTGATCCCCAACGCTTCACAAGCAGAGAGCAAAGTCTTCTATTTGAAA 
             ************************************************************ 
 
cow          ATGAAAGGAGACTACTACCGCTACTTGGCTGAGGTTGCAGCTGGTGATGACAAGAAAGGG 
buffalo      ATGAAAGGAGACTACTACCGCTACTTGGCTGAGGTTGCAGCTGGTGATGACAAGAAAGGG 
             ************************************************************ 
 
cow          ATTGTGGACCAGTCACAGCAAGCATACCAAGAAGCTTTTGAAATCAGCAAAAAGGAAATG 
buffalo      ATTGTGGATCAGTCGCAGCAAGCATACCAAGAAGCTTTTGAAATCAGCAAAAAGGAAATG 
             ******** ***** ********************************************* 
 
cow          CAACCAACACATCCTATCAGACTGGGTCTGGCCCTTAACTTCTCTGTGTTCTATTATGAG 
buffalo      CAACCAACACATCCTATCAGACTGGGTCTGGCCCTTAACTTCTCTGTGTTCTATTATGAG 
             ************************************************************ 
 
cow          ATTCTGAACTCCCCTGAGAAAGCCTGCTCTCTTGCAAAGACAGCATTTGATGAAGCCATT 
buffalo      ATTCTGAACTCCCCTGAGAAAGCCTGCTCTCTTGCAAAGACAGCATTTGATGAAGCCATT 
             ************************************************************ 
 
cow          GCTGAACTTGATACATTAAGTGAAGAGTCATACAAAGACAGCACGCTAATAATGCAGTTA 
buffalo      GCTGAACTTGATACATTAAGTGAAGAGTCATACAAAGACAGCACGCTAATAATGCAGTTA 
             ************************************************************ 
 
cow          CTGAGAGATAACTTGACATTGTGGACATCGGATACCCAAGGAGACGAAGCTGAAGCAGGA 
buffalo      CTGAGAGATAACTTGACATTGTGGACATCGGATACCCAAGGAGACGAAGCTGAAGCAGGA 
             ************************************************************ 
 
cow          GAAGGAGGGGAAAATTAA 
buffalo      GAAGGAGGGGAAAATTAA 
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PPIA:  98.96% nucleotide homology between cattle and buffalo sequences. 
cow          ATGGTCAACCCCACCGTGTTCTTCGACATCGCTGTCGACGGCGAGCCCTTGGGCCGCGTC 
buffalo      ATGGTCAACCCCACCGTGTTCTTCGACATCGCCGTCGACGGCGAGCCCTTGGGCCGCGTC 
             ******************************** *************************** 
 
cow          TCTTTTGAGCTGTTTGCAGACAAAGTTCCAAAGACAGCAGAAAACTTTCGTGCTCTGAGC 
buffalo      TCTTTTGAGCTGTTTGCAGACAAAGTTCCAAAGACAGCAGAAAACTTTCGTGCTCTGAGC 
             ************************************************************ 
 
cow          ACTGGAGAGAAAGGATTTGGTTATAAAGGTTCCTGCTTTCACAGAATAATTCCGGGATTT 
buffalo      ACTGGAGAGAAAGGATTTGGTTATAAAGGTTCCTGCTTTCACAGAATAATTCCGGGATTT 
             ************************************************************ 
 
cow          ATGTGCCAGGGTGGTGACTTCACACGCCATAATGGTACTGGTGGCAAGTCCATCTATGGC 
buffalo      ATGTGCCAGGGTGGTGACTTCACACGCCATAATGGTACTGGTGGCAAGTCCATCTATGGC 
             ************************************************************ 
 
cow          GAGAAATTTGATGATGAGAATTTCATTTTGAAGCATACAGGTCCTGGCATCTTGTCCATG 
buffalo      GAGAAATTTGATGATGAGAATTTCATTCTGAAGCATACAGGTCCTGGCATCTTGTCCATG 
             *************************** ******************************** 
 
cow          GCAAATGCTGGCCCCAACACAAATGGTTCCCAGTTTTTCATTTGCACTGCCAAGACTGAG 
buffalo      GCAAATGCTGGCCCCAACACAAATGGTTCCCAGTTTTTCATCTGCACTGCCAAGACTGAG 
             ***************************************** ****************** 
 
cow          TGGTTGGATGGCAAGCACGTGGTACTTTGGCAAGGTGAAAGAGGGCATGAATATTGTGGA 
buffalo      TGGTTGGATGGCAAGCATGTGGTC-TTTGGCAAGGTGAAAGAGGGCATGAATATTGTGGA 
             ***************** *****  *********************************** 
 
cow          AGCCATGGAGCGCTTTGGGTCCAGGAATGGCAAGACCAGCAAGAAGATCACCATTGCTGA 
buffalo      AGCCATGGAGCGCTTTGGGTCCAGGAATGGCAAGACCAGCAAGAAGATCACCATTGCTGA 
             ************************************************************ 
 
 
H3F3A: 100% nucleotide homology between cattle and buffalo sequences. 
cow          ATGGCTCGTACAAAGCAGACTGCCCGCAAATCGACCGGTGGTAAAGCACCGAGGAAGCAA 
buffalo      ATGGCTCGTACAAAGCAGACTGCCCGCAAATCGACCGGTGGTAAAGCACCGAGGAAGCAA 
             ************************************************************ 
 
cow          CTCGCTACAAAAGCCGCTCGCAAGAGTGCGCCCTCTACTGGAGGGGTGAAGAAACCTCAT 
buffalo      CTCGCTACAAAAGCCGCTCGCAAGAGTGCGCCCTCTACTGGAGGGGTGAAGAAACCTCAT 
             ************************************************************ 
 
cow          CGTTACAGGCCTGGTACTGTGGCACTCCGTGAAATTAGACGTTATCAGAAGTCCACTGAA 
buffalo      CGTTACAGGCCTGGTACTGTGGCACTCCGTGAAATTAGACGTTATCAGAAGTCCACTGAA 
             ************************************************************ 
 
cow          CTTCTGATTCGCAAACTTCCCTTCCAGCGTCTGGTGCGGGAAATTGCTCAGGACTTCAAA 
buffalo      CTTCTGATTCGCAAACTTCCCTTCCAGCGTCTGGTGCGGGAAATTGCTCAGGACTTCAAA 
             ************************************************************ 
 
cow          ACAGATCTGCGCTTCCAGAGTGCAGCTATTGGTGCTTTGCAGGAGGCAAGTGAGGCCTAT 
buffalo      ACAGATCTGCGCTTCCAGAGTGCAGCTATTGGTGCTTTGCAGGAGGCAAGTGAGGCCTAT 
             ************************************************************ 
 
cow          CTGGTTGGCCTTTTTGAAGACACCAACCTGTGTGCTATCCATGCCAAACGTGTAACAATT 
buffalo      CTGGTTGGCCTTTTTGAAGACACCAACCTGTGTGCTATCCATGCCAAACGTGTAACAATT 
             ************************************************************ 
 
cow          ATGCCAAAAGACATCCAGCTAGCACGCCGCATACGTGGAGAACGTGCTTAA 
buffalo      ATGCCAAAAGACATCCAGCTAGCACGCCGCATACGTGGAGAACGTGCTTAA 
             *************************************************** 
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TBP: 99.47% nucleotide homology between cattle and buffalo sequences. 
cow          ATGGATCAGAACAACAGCCTCCCACCCTATGCCCAGGGCCTGGCCTCCCCTCAGGGTGCC 
buffalo      ATGGATCAGAACAACAGCCTCCCACCGTATGCCCAGGGCCTGGCCTCCCCTCAGGGTGCC 
             ************************** ********************************* 
 
cow          ATGACTCCTGGAATCCCTATCTTTAGTCCAATGATGCCTTACGGCACAGGACTGACTCCA 
buffalo      ATGACTCCTGGAATCCCTATCTTTAGTCCAATGATGCCTTACGGCACAGGACTGACTCCA 
             ************************************************************ 
 
cow          CAGCCTATTCAGAACACCAACAGTCTGTCTATTCTGGAGGAGCAGCAACGGCAGCAGCAG 
buffalo      CAGCCTATCCAGAACACCAACAGTCTGTCTATTCTGGAGGAGCAGCAACGGCAGCAGCAG 
             ******** *************************************************** 
 
cow          CAGCAGCAACAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGGCGGCAGTGGCA 
buffalo      CAGCAGCAACAGCAG------------CAGCAGCAGCAGCAGCAGCAGGCAGCAGTGGCA 
             ***************            *********************** ********* 
 
cow          GCCGTCCAGCAGTCGACGTCCCAGCAGGCAACCCAGGGGCCCTCGGGCCAGACACCACAG 
buffalo      GCCGTCCAGCAGTCGACGTCCCAGCAGGCAACCCAGGGGCCCTCGGGCCAGACACCACAG 
             ************************************************************ 
 
cow          CTCTTCCACTCACAGACTCTTACGACTGCACCCTTGCCGGGCACCACTCCCTTGTATCCC 
buffalo      CTCTTCCACTCACAGACTCTTACGACTGCACCCTTGCCGGGCACCACTCCCTTGTATCCC 
             ************************************************************ 
 
cow          TCCCCCATGACCCCCATGACCCCCATCACCCCTGCCACGCCAGCCTCAGAGAGCTCCGGG 
buffalo      TCCCCCATGACCCCCATGACCCCCATCACCCCTGCCACGCCAGCCTCAGAGAGCTCCGGG 
             ************************************************************ 
 
cow          ATCGTGCCGCAGCTGCAAAATATTGTATCCACAGTGAATCTTGGTTGTAAACTTGACCTA 
buffalo      ATCGTGCCGCAGCTGCAAAATATTGTATCCACAGTGAATCTTGGTTGTAAACTTGACCTA 
             ************************************************************ 
 
cow          AAGACCATTGCACTTCGTGCCCGAAATGCTGAATATAATCCCAAGCGTTTTGCTGCTGTA 
buffalo      AAGACCATTGCACTTCGTGCCCGAAATGCTGAATATAATCCCAAGCGTTTTGCTGCTGTA 
             ************************************************************ 
 
cow          ATCATGAGAATAAGAGAGCCCCGCACCACTGCACTGATATTCAGTTCTGGGAAGATGGTG 
buffalo      ATCATGAGAATAAGAGAGCCCCGCACCACTGCACTGATATTCAGTTCTGGGAAGATGGTG 
             ************************************************************ 
 
cow          TGCACAGGAGCCAAGAGTGAAGAACAGTCTAGACTAGCAGCAAGAAAATACGCCAGAGTT 
buffalo      TGCACAGGAGCCAAGAGTGAAGAACAGTCTAGATTAGCAGCAAGAAAATACGCCAGAGTT 
             ********************************* ************************** 
 
cow          GTACAGAAACTGGGTTTTCCAGCTAAGTTCTTGGACTTCAAGATTCAGAACATGGTGGGG 
buffalo      GTACAGAAACTGGGTTTTCCAGCTAAGTTCTTGGACTTCAAGATTCAGAACATGGTGGGG 
             ************************************************************ 
 
cow          AGCTGTGATGTGAAGTTCCCTATAAGGTTAGAAGGCCTTGTGCTTACCCACCAACAGTTC 
buffalo      AGCTGTGATGTGAAGTTCCCTATAAGGTTAGAAGGCCTTGTGCTTACCCACCAACAGTTC 
             ************************************************************ 
 
cow          AGTAGTTATGAGCCAGAGTTATTTCCTGGTTTAATCTACAGAATGATCAAACCGAGAATT 
buffalo      AGTAGTTATGAGCCAGAGTTATTTCCTGGTTTAATCTACAGAATGATCAAACCGAGAATT 
             ************************************************************ 
 
cow          GTTCTCCTTATTTTTGTTTCTGGAAAAGTTGTATTAACAGGTGCTAAAGTCAGAGCAGAA 
buffalo      GTTCTCCTTATTTTTGTTTCTGGAAAAGTTGTATTAACAGGTGCTAAAGTCAGAGCAGAA 
             ************************************************************ 
 
cow          ATTTATGAAGCCTTTGAGAACATCTACCCTATTCTGAAGGGTTTCAGGAAGACAACGTAA 
buffalo      ATTTATGAAGCCTTTGAGAACATCTACCCTATTCTGAAGGGTTTCAGGAAGACTACGTAA 
             ***************************************************** ****** 
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HPRT1: 99.09% nucleotide homology between cattle and buffalo sequences. 
cow          ATGGCGGCCCGCAGCCCCAGCGTGGTGATTAGCGATGATGAACCAGGTTATGACCTAAAT 
buffalo      ATGGCGGCCCGCAGTCCCAGCGTGGTGATTAGCGATGATGAACCAGGTTATGACCTAAAT 
             ************** ********************************************* 
 
cow          TTATTTTGTATACCCAATCATTATGCTGAGGATTTGGAGAAGGTGTTTATTCCTCATGGA 
buffalo      TTATTTTGTATACCCAATCATTATGCTGAGGATTTGGAGAAAGTGTTTATTCCTCATGGA 
             ***************************************** ****************** 
 
cow          CTAATTATGGACAGGACCGAACGGCTGGCTCGAGATGTGATGAAGGAGATGGGTGGCCAT 
buffalo      CTAATTATGGACAGGACCGAACGACTGGCTCGAGATGTGATGAAGGAGATGGGTGGCCAT 
             *********************** ************************************ 
 
cow          CACATTGTGGCCCTCTGTGTGCTCAAGGGGGGCTATAAGTTCTTTGCCGACCTGTTGGAT 
buffalo      CACATTGTGGCCCTCTGTGTGCTCAAGGGGGGCTATAAGTTCTTTGCTGACCTGTTGGAT 
             *********************************************** ************ 
 
cow          TACATCAAAGCACTGAACAGAAATAGTGACAAATCCATTCCTATGACTGTGGATTTTATC 
buffalo      TACATCAAAGCACTGAACAGAAATAGTGACAAATCCATTCCTATGACTGTGGATTTTATC 
             ************************************************************ 
 
cow          AGACTGAAGAGCTACTGTAACGACCAGTCAACAGGCGACATAAAAGTAATTGGTGGAGAT 
buffalo      AGACTGAAGAGCTACTGTAACGACCAGTCAACAGGCGACATAAAAGTAATTGGTGGAGAT 
             ************************************************************ 
 
cow          GATCTCTCAACTTTAACTGGAAAGAATGTCTTGATTGTCGAAGATATAATTGACACTGGG 
buffalo      GATCTCTCAGCTTTAACTGGAAAGAATGTCTTGATTGTCGAAGATATAATTGACACTGGA 
             ********* *************************************************  
 
cow          AAGACAATGCAGACTTTGCTTGCCTTGGTCAAGAAGCATAAACCAAAGATGGTCAAGGTT 
buffalo      AAGACAATGCAGACTTTGCTTGCCTTGGTCAAGAAGCATAAACCAAAGATGGTCAAGGTT 
             ************************************************************ 
 
cow          GCGAGCTTGCTGATGAAAAGGACCCCTCGAAGTGTTGGATATAAACCAGACTTTGTTGGA 
buffalo      GCGAGCTTGCTGATGAAAAGGACCCCTCGAAGTGTTGGATATAAACCAGACTTTGTTGGA 
             ************************************************************ 
 
cow          TTTGAAATTCCAGACAAGTTTGTTGTGGGATATGCCCTTGACTATAATGAATACTTCAGG 
buffalo      TTTGAAATTCCAGACAAGTTTGTTGTGGGATATGCCCTTGACTATAATGAATACTTCAGG 
             ************************************************************ 
 
cow          GACTTGAATCACGTGTGTGTCATTAGCGAAACTGGAAAAGCAAAATACAAAGCCTAA 
buffalo      GACTTGAATCACGTGTGTGTCATTAGCGAAACTGGAAAAGCAAAATACAAAGCCTAA 
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